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Amphiphilic peptides are biodegradable and biocompatible, important 
characteristics for ideal drug carriers. They can form nano-sized micelles with 
hydrophobic cores allowing for encapsulation of hydrophobic drugs, and thus 
provide an effective protection against hydrolysis and degradation. In addition, 
the size, stability, permeability and elasticity of the micelles can be fine-tuned by 
tailoring peptide sequence, length, solution conditions, etc. The micelles may 
undergo structural transition triggered by pH variation or other stimuli leading to 
drug release. Therefore, amphiphilic peptides have received considerable interest 
for drug delivery. Nevertheless, there is no theoretical guidance currently 
available on the rational selection and design of amphiphilic peptides to achieve 
optimal drug delivery.  
Through molecular dynamics simulation, the objective of this thesis is to 
quantitatively understand the self-assembly behavior of amphiphilic peptides from 
a microscopic scale, elucidate the detailed process of drug loading and release, 
and provide bottom-up guidelines towards the intelligent design of new 
amphiphilic peptides for drug delivery. The main contents of the thesis contain 
four parts.  
(1) Self-assembly of short amphiphilic peptides FmDn and FmKn is examined. 
Within s-scale simulation, FD and FK only form loose polymeric clusters. Upon 
increasing the length of Phe residues in FmD and FmK (m = 2 to 4), larger and 
more stable micelles are formed. FmK and FmD prefer to assemble into quasi-
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spherical and sheet-like micelles, respectively. For F3Kn (n = 2 to 8) and F6Kn (n = 
4 to 12), the assembly capability reduces leading to smaller micelles when the 
length of Lys residues increases. For the formation of quasi-spherical micelles 
with distinct core/shell structure, the optimal ratio of hydrophobic/hydrophilic 
residues is found to be 3/4 for both F3Kn and F6Kn. 
(2) A relatively longer amphiphilic peptide FA32 [(AF)6H5K15] is studied. 
Spherical micelles are formed, with Ala and Phe in hydrophobic core, Lys in 
hydrophilic shell and His at core/shell interface. The assembly process and 
microscopic structures are analyzed in terms of the number of clusters, the radii of 
micelle, core and shell and the density profiles of residues.  It is found that the 
micellar structures and microscopic properties are essentially independent of the 
size of simulation box. With increasing concentration, quasi-spherical micelles 
change to elongated shape and micelle size generally increases.  
(3) The effects of hydrophilic and hydrophobic chain lengths on self-assembly 
are studied. With increasing length of hydrophilic Lys residues in (AF)6H5Kn (n = 
10, 15, 20 and 25), the assembly capability is reduced by forming smaller micelles 
or the presence of individual peptide chains. Upon replacing Ala by more 
hydrophobic Phe in AmFnH5K15 (m + n = 12), larger micelles are formed. With 
increasing length of hydrophobic Phe residues in FnH5K15 (n = 4, 8, 12 and 16), 
micelle size increases and the morphology shifts from spherical to fiber-like.  
(4) A model hydrophobic drug, ibuprofen (IBU), is investigated for loading 
and release in FA32, F12H5K15 and F16H5K15. Upon the loading of IBU in FA32, 
quasi-spherical core/shell structured micelles are formed. IBU is predominantly 
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located in hydrophobic core and covered by Phe and Ala residues, while Lys is in 
the hydrophilic shell. With increasing concentration of IBU, the radii of micelle 
and core increase. In F16H5K15, however, the loading of IBU leads to a well-
structured nanofiber. The release of IBU from FA32 micelles is slower than from 
F16H5K15 nanofiber, suggesting the former is better in controlled release. 
Furthermore, the effects of peptide sequence on IBU loading are investigated in 
(AF)6H5K15, H5(AF)6K15, H5K5(AF)6K10 and (AF)3H5K15(AF)3. It is revealed that 
peptide sequence has an insignificant effect on drug loading.  
From this thesis, microscopic insights into the self-assembly of amphiphilic 
peptides, and the loading and release of drug are provided. Equilibrium and 
dynamic properties are obtained from a molecular level. Key governing factors 
such as chain length, sequence and hydrophobicity have been identified. The 
bottom-up guidelines are useful towards the development of new amphiphilic 
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Chapter 1. Introduction 
1.1 Background 
Conventional cancer treatments are limited to surgery, chemotherapy and 
radiation. Surgery is to remove tumors in human body. Chemotherapy uses 
medicines to destroy cancer cells. In radiation treatment, high-energy radiations 
are used to kill or decline the growth of cancer cells.
1
 Apart from these methods, 
additional techniques such as transplantation and gene therapy are in pre-clinical 
development stage.
2
 While killing cancer cells, chemotherapy and radiation also 
kill healthy cells, which is a main concern in cancer treatment. To overcome this 
limitation, some alternatives such as targeted and sustained drug delivery have 
been proposed. Targeted delivery can effectively inhibit the growth of cancer cells 
and causes less damage to healthy cells, and sustained release offer several 




In targeted and sustained delivery, drug carrier materials play an indispensable 
role. Over the last two decades, numerous experimental studies have been 
reported on developing advanced materials as drug carriers.
4-6
 Initially, low 
molecular weight surfactants were used for encapsulation of drugs.
7-9
 However, 
surfactants have less micellization capacity compared to block copolymers and 
drug-loaded surfactants tend to rapidly dissociate drug into blood (kinetically 
unstable).
10
 Consequently, copolymers have received considerable attention for 
drug delivery, for example, poly ethylene oxide (PEO) and poly l-amino acids 






 By changing polymer structure, different carriers could be derived 
with improved properties in terms of drug loading, sensitivity to local 
environment, release and kinetic stability. However, some polymers are cytotoxic 
to host cells
12,13
 and cannot be clinically used. Ideal carriers for drug delivery 
should possess certain characteristics such as nontoxic, non-immunogenic, 
biocompatible, biodegradable and kinetically stable.
11
 In this context, amphiphilic 
peptides have emerged as “smart” materials for drug delivery. They were tested 
for delivering drug or gene or both, and better therapeutic effects were found on 
cancer cells or genetic disorders.
14










. Every year, about 17 new peptides enter into clinical studies and about 
140 peptides are currently in the development stage.
5
  
Amphiphilic peptides are composed of hydrophilic and hydrophobic blocks 









 as illustrated in Figure 1.1.  
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The morphologies formed are dependent on the ratio of hydrophobic to 
hydrophilic blocks, peptide sequence, concentration, and other factors. Generally, 
hydrophilic blocks favor to form micelles, hydrophobic blocks would produce 




The morphologies formed by peptides can encapsulate drug molecules and 
deliver drug to cancer cells. Their size is usually less than 100 nm, which is an 
advantage to hide from reticuloendothelial system (RES) of human body.
11
 In 
addition, the hydrophilic shell can keep the structures untraceable during blood 
circulation.
25
 More importantly, their size, stability, permeability and elasticity 
can be fine-tuned by tailoring peptide sequence, length, solution conditions, etc. 
With 20 naturally occurring amino acids, it can be envisioned that tremendously 
large number of peptides would be explored. 
1.2 Amino Acids 
Peptides are composed of amino acids as the basic building blocks connected by 
peptide bonds (-CO-NH-). Each amino acid has a central α-carbon atom attached 
with four different groups including a basic amino group (-NH2), an acidic group 
(-COOH), a hydrogen atom (-H) and a functional side chain (-R). As illustrated in 
Figure 1.2, a peptide bond is formed between the carbon atom of carboxyl group 
in one amino acid and the nitrogen atom of amine group in the other amino acid. 
Peptides usually consist of 2-50 amino acids, and long chains of peptides are 
known as proteins. There are 20 naturally occurring amino acids (see Figure 1.3) 
utilized in the synthesis of peptides and proteins in biological cells.
26
 Therefore, 




almost unlimited number of peptides can be formed with various arrangements 
and combinations of 20 amino acids.  
 
Figure 1.2. Representation of peptide bond formation between two amino acids. 
  
 








Depending on the side chain functional groups, amino acids possess different 
properties. Table 1.1 lists the physical properties (e.g. pKa and hydropathy index). 
Different classifications exist for the 20 amino acids based on the functionality of 
side chain, polarity, essential or non-essential, etc. Among these, hydrophobicity 
and polarity-based classifications are the most commonly used. Specifically, 
amino acids are classified into hydrophobic, hydrophilic, charged and others. The 
hydrophobic amino acids are further classified into aliphatic (A, I, L, M and V) 
and aromatic (F, W and Y); the hydrophilic amino acids (S, N, T and Q) possess 
hydrogen bonding capability; the charged amino acids are either positively 
charged (H, R and K) or negatively charged (D and E); the remaining (C, P and 
G) belong to the others. 
Another classification is based on polarity, including polar charged, polar 
uncharged and nonpolar types.
27
 The polar charged amino acids (K, R, H, D and 
E) have two subtypes namely acidic (negatively charged D, E) and basic 
(positively charged K, R and H); the polar uncharged include S, T, N, Q, Y and C; 
nonpolar type are G, A, V, L, I, M, P, F and W. One more type of classification is 
based on nutritional supplement to human body by internal metabolism (non-
essential) or external supplements (essential). Out of 20 amino acids, human body 
can produce 11 that are typically non-essential, the remaining 9 have to be 
procured by external supplements such as food and known as essential amino 
acids (I, L, K, M, F, T, W and V). 
 
 













Alanine 89.09 ALA - A   0.62 
Glycine 75.07 GLY - G   0.48 
Serine 105.09 SER - S   -0.18 
Threonine 119.12 THR - T   -0.05 
Cysteine 121.16 CYS - C 8.37 0.29 
Valine 117.15 VAL - V   1.08 
Leucine 131.18 LEU - L   1.06 
Isoleucine 131.18 ILE - I   1.38 
Methionine 149.21 MET - M   0.64 
Proline 115.13 PRO - P   0.12 
Phenylalanine 165.19 PHE - F   1.19 
Tyrosine 181.19 TYR - Y 10.46 0.26 
Tryptophan 204.23 TRP - W   0.81 
Aspartic Acid 133.1 ASP - D 3.9 -0.90 
Glutamic Acid 147.13 GLU - E 4.07 -0.74 
Asparagine 132.12 ASN - N   -0.78 
Glutamine 146.15 GLN - Q   -0.85 
Histidine 155.16 HIS - H 6.04 -0.40 
Lysine 146.19 LYS - K 10.54 -1.50 
Arginine 174.2 ARG - R 12.48 -2.53 





Due to biocompatibility and biodegradation, amphiphilic peptides derived from 







 and tissue engineering.
29
 Some peptides also 
have antimicrobial activities without damaging normal cells.
17
 The applications of 
peptides are briefly described below. 
1.3.1 Antimicrobial Activities 
Interacting with microbes, short cationic amphiphilic peptides can disrupt cell 
membranes and thus facilitate the removal of microbes (e.g. bacteria and fungi). 
This kind of action is much more effective than conventional antibiotics, which 
are primarily focused on the inhibition of bacterial growth. For example, A9K 
peptide forms positively charged nano-packed rods and interacts with the cell 
membranes of bacteria as shown in Figure 1.4. Consequently, A9K shows the best 
killing capacity against Gram-positive and Gram-negative bacteria.
17
 As a 
combination of dipeptides and acyl carbon chains (C14), lipopeptides were found 
to be capable of inhibition of Gram positive and Gram negative bacteria and 
fungus.
30
 Chu-Kung et al. observed that the conjugation of fatty acid to peptides 
exhibited improved antimicrobial activity.
31
 Yang group designed a novel 
cholesterol conjugated peptide (Chol-G3R6YGRK2R2QR3) forming core/shell 
structured nanoparticles. These nanoparticles had strong antimicrobial properties 
against a range of bacteria and could cross the blood brain barrier to reduce 
bacterial infectious growth.
32
 Such nanoparticles are promising antimicrobial 




agents to treat brain infectious diseases without toxicity to other organs. A recent 




Figure 1.4. Schematic illustrations of actions of A9K leading toward bacterial 
membrane permeation and disruption. (a) A9K molecules self-assemble into 
nanorods (red) with the positive charges outside the rod. (b) A9K molecules flap 
on to outer membrane surface through charge affinity and may become inserted in 
the membrane through hydrophobic effect. (c) They can then flip to insert into the 
inner leaf of the membrane and make a “through barrel” or micelles to cause 
leakage or lysis. (d) Nanorods might also associate with the cell membrane 
surface directly through charge interaction and (e) become inserted subsequently 
due to different effects including electrostatic and hydrophobic interactions.
17
 
1.3.2 Nano Fabrication 
Amphiphilic peptides can form nanofibers and circuits. Stupp group has designed 
and synthesized such peptides from a C16 tail and a peptide containing cysteine 
residues. The self-assembled nanofibers were robust and pH invariant due to the 




presence of disulfide bonds, and useful in mineralization of hydroxyapatite.
34
 In 
another study, they attached a C16 chain to various sequences of peptides that 
formed cylindrical nanofibers with peptide sequences in β-sheet structured 
outwards. The high degree of internal ordered structures of these fibers promoted 
them as alternatives for the epitaxial growth of minerals.
35
 The fatty acid 
conjugated peptide amphiphiles were utilized as bioactive materials to coat bone 
implants
36
 and 3D-bone matrix mineralization.
37
 Short surfactant-like peptides 
(A6D) were designed to fabricate donut-like structures by the fusion of 
intermediate structures during assembly as shown in Figure 1.5. These structures 





Figure 1.5. Proposed plausible self-assembly process of the nanodonut structure. 
(A) Randomly oriented and distributed peptides at low concentration. (B) Micelle 
formation above the CAC concentration. (C) Fusion or elongation of the micelles 









1.3.3 Drug and Gene Delivery  
The hydrophobic core and hydrophilic shell formed by amphiphilic peptides can 
be used for drug delivery. With synergistic therapeutic effect, cationic 
amphiphilic peptides have been tested for both hydrophobic drugs and genes.
14,39
 
For example, cholesterol conjugated peptides H5R10 (Chol-HR15) and H10R10 
(Chol-HR20) were found to form cationic micelles showing effective binding of 
DNA and a high level of gene expression, thus they are promising gene delivery 
carriers.
40
 Amphiphilic oligopeptides A12H5K10 (AK27) and A12H5K15 (AK32) 
were synthesized for in vitro gene expression studies, and improved gene 
expression was observed when compared to Chol-HR15 and Chol-HR20.
41
 
Different peptides were designed by replacing alanine with phenylalanine, leading 
to stronger hydrophobic interaction and thus reducing the critical micelle 
concentration (CMC).
39
 (AF)6H5K15 (FA32) was found to form core/shell 
structured micelles, which exhibited co-delivery of therapeutic gene (p53) along 
with doxorubicin (DOX) simultaneously into the cells.
14
 Apart from core/shell 
morphologies, there are other morphologies that can deliver drugs. Zarzhitsky et 
al. studied the delivery DOX using a peptide P5D(FD)5P, which formed a 
hydrogel based on electrostatic and hydrophobic interactions.
42
 The hydrogel was 
able to load DOX effectively and displayed a sustained release as shown in Figure 
1.6. A number of reviews have summarized the applications of peptides in drug 
delivery,
4
 drug and gene delivery,
18
 as well as cancer nanomedicine.
5
  





Figure 1.6. (a) Images of DOX loaded PFD-5 hydrogel shaped on a glass slide by 
a syringe. (b) DOX loaded hydrogel in a well prior to the addition of medium 
(left) and fragmented hydrogel on the sixth day in medium (right) showing the 




1.3.4 Cosmetic and Skin Care Applications  
Due to biocompatible feature, peptides show anti-wrinkle and anti-microbial 
activities, and thus can be utilized as nutrients for skin care and replace traditional 
surfactants for cleaning and foaming actions. A typical short lipopeptide (C16–
KTTKS) known as Matrixyl, which is similar to collagen type I, has been used in 
many skin care products.
43,44
 Another lipopeptide (C16-GHK) is part of the 
ingredient of Matrixyl
TM
 3000, which is helpful in signaling of fibroblast cells to 
derive new skin surface. Peptide fragments derived from immunoglobulin G were 




1.3.5 Other Applications  
Certain amphiphilic peptides are specific to bind particular biomolecules and can 
be applied in biosensing. For example, C16–LRKKLGKA designed by Stupp and 
coworkers exhibited a specific binding with heparin due to electrostatic 
interactions and stimulated to grow new blood vessels at the in vivo nanoscale.
46
 




Laromine et al. attached a short peptide (Fmoc-GFC-NH2) to gold nanoparticles, 
leading to a change from blue to red color visible to naked eye. The system also 
detected enzyme with a high sensitivity.
47
 In addition, short diphenylalanine was 
utilized by Reches and Gazit as a template to construct a uniform silver nanowire. 
The diphenylalanine self-assembled into stiff nanotubes in which ionic silver was 
reduced, and the degradation of peptide backbone by Proteinase K yielded a fine 





Figure 1.7. Casting of silver nanowires with the peptide nanotubes. (A) The 
nanowires were formed by the reduction of silver ions within the tubes, followed 
by enzymatic degradation of the peptide mold. (B) TEM analysis (without 
staining) of peptide tubes filled with silver nanowires. (C and D) TEM images of 
silver nanowires that were obtained after the addition of the proteinase K enzyme 




In the above mentioned applications, the structures assembled from 
amphiphilic peptides play a key role in their performance. The morphologies 
depend on the interactions between peptides, as well as between peptides and 




guest molecules. Fundamental understanding of self-assembly process is thus 
critical to the screening and design of ideal peptides for specific applications.  
1.4 Objectives and Scope of the Thesis 
There has been continuous increase in the incidence and mortality rate of cancer  
for a few decades.
49
 Despite the development of new drugs, immediate treatment 
is still lacking due to the high cost of drugs.
50,51
 It is economically more feasible 
to develop better delivery method for existing drugs rather than inventing new 
drugs. Current delivery materials such as surfactants and copolymers have been 
tested and few of them are in clinical trials;
52-57
 however, the instability and 
toxicity impede their popular use.
58
 Amphiphilic peptides turn out to be good 
alternatives because of their biodegradability, biocompatibility and readily 
tunable structures based on 20 amino acids.
5
  
The self-assembly of amphiphilic peptides and resulting morphologies are the 
key in their utility as new drug carriers.
59-63
 One may expect peptides with 
hydrophobic and hydrophilic residues will assemble, but cannot 
reliably/accurately predict the type of final morphology. In more detail, peptides 
can form spherical, cylindrical or lamellar structure, or fiber, rod, disc-like, and 
even more complex morphologies. Which morphology that will be formed at an 
intermediate or final state, as well as the dynamic structural transition during 
assembly, is not obvious! Although a large number of experimental studies have 
been reported, there is no theoretical guidance currently available on the rational 
selection of amphiphilic peptides to achieve optimal drug delivery. In this context, 
simulation can provide microscopic insights that otherwise are experimentally 




inaccessible or difficult to obtain, and thus assist in the rational screening and 
design of novel peptides. The objective of this thesis is to quantitatively 
understand the self-assembly of amphiphilic peptides with various hydrophobic 
and hydrophilic moieties, elucidate the detailed process of drug loading and 
release, and provide bottom-up guidelines towards the intelligent design of new 
amphiphilic peptides for high-efficacy drug delivery.  
The thesis is organized in nine chapters. Chapter 1 describes the basic 
properties of amino acids, the applications of peptides and the scope of the thesis. 
Chapter 2 summarizes the existing studies on surfactant-like peptides, lipid-based 
peptides and amphiphilic peptides. Simulation methodology and other 
computational details are briefly mentioned in Chapter 3. Chapter 4 examines the 
assembly of short amphiphilic peptides FmDn and FmKn by changing the ratio of 
hydrophilic to hydrophobic residues. Chapter 5 studies the assembly of a 
relatively longer peptide FA32 [(AF)6H5K15], with a focus on the effects of 
simulation box size and peptide concentration. The effects of hydrophobic and 
hydrophilic residues on the assembly of FA32 derivatives are investigated in 
Chapter 6. In Chapter 7, the loading and release of ibuprofen as a model 
hydrophobic drug are examined. The effects of peptide sequence on self-assembly 
and ibuprofen loading are discussed in Chapter 8. Finally, the conclusions and 
recommendations for future work are outlined in Chapter 9.  
 




Chapter 2. Literature Review 
A large number of studies mostly experimentally-based have been reported in the 
literature on the self-assembly of peptides. The peptides examined can be 
categories into three types: surfactant-like peptides that appear like surfactants 
with charged hydrophilic amino acids connected to hydrophobic residues; lipid-
based peptides in which carbon chains act as hydrophobic tails and are attached to 
amino acids; and amphiphilic peptides in which both hydrophobic and hydrophilic 
blocks are of amino acids.  
2.1 Surfactant-Like Peptides 
Zhang and co-workers extensively investigated the assembly of surfactant-like 
peptides. In a series of anionic peptides (A6D, V6D, V6D2 and L6D2) with aspartic 
acid as hydrophilic head and alanine, valine or leucine as hydrophobic tail, they 
observed the formation of nanotubes and nanovesicles with an average diameter 
of 30-50 nm.
64
 Increase in hydrophobicity (A6D to V6D) reduced the critical 
aggregation concentration (CAC) from 1.6 to 0.5 mM.
65
 In a similar study, the 
variation of glycine chain length (G4D2, G6D2, G8D2 and G10D2) with two aspartic 
acids as hydrophilic head was examined. Increase in glycine chain length resulted 
in the formation of vesicles, apart from nanotubes, with an average size of 40-80 
nm.
23
 Furthermore, cationic charged peptides (A6K, V6K, V6H, KV6, H2V6, V6K2 
and L6K2) containing one or two residues of lysine or histidine and six residues of 
alanine, valine or leucine were studied.
66
 At pH below pI, these peptides formed 
nanotubes and vesicles with size ranging from 50 nm to 100-200 nm, respectively. 




At pH above pI, membrane-like structures were formed. Zhang and coworkers 
also designed a cone-shaped amphiphilic peptide (GAVILRR), which formed a 
donut shaped structures along with small micelles.
38
 Using atomic force 
microscopy (AFM) and dynamic light scattering (DLS), they explored the 
synergistic effect of mixing two peptides (Ac-A6D-OH, Ac-A6K-NH2) at different 
molar ratios and observed the formation of uniform nanoropes at a ratio of 1:2 
(A6D:A6K).
67




In three cationic peptides I6K2, L6K2 and V6K2, Baumann et al. found I6K2 
with tail forming β-sheet turned into sheets, while L6K2, V6K2 with tails forming 
random coils yielded micellar rods. The monomer concentration was shown a 
significant effect on the sheet area and rod length.
69
 Lu and co-workers examined 
short peptides (A3K, A6K and A9K) with lysine as hydrophilic head, which had 
structural transitions among sheets, fibers and nanorods, as well as a reduction in 
critical micelle concentration (CMC) with increasing hydrophobic length.
70
 In 
these peptides, the dynamics of structural transitions was studied by Wang et al. 
A6K initially formed short globular stacks then merged into nanofibers; however, 
A9K assembled into stable nanorods in a quicker manner with a diameter of 3-4 
nm and a length of 10 nm.
71
 It should be point out that A6K was observed to form 
nanotubes by other groups.
72,73
 Han et al. examined the cooperative effect 
between hydrogen bonding and hydrophobic interaction on the self-assembly of 
I3K, LI2K, L3K, L4K, L5K, I4K and I5K. All ImK showed nanofiber structures 
because of β-sheet conformation, while L3K formed globular micelles due to 




relatively weak secondary structures; with increasing leucine length, L5K also 
formed a nanofiber. Therefore, a change in hydrophobic interaction and swapping 
of leucine with isoleucine could alter the shape and size of nanostructures.
74
 
Depending on the sequence and purity of peptide, a diversity of structures such as 
fiber, tape and twisted ribbon were observed by Adams et al. in V6D2, V5DVD and 
V4D2V2.
75
 The effect of sequence on morphology was examined by Zhao et al. in 
I2K2I2, I4K2 and KI4K. With the capability of forming β-sheet, I4K2 and KI4K 
assembled into nanofibrils and nanotubes, respectively, whereas no well-defined 
alignment was formed in I2K2I2 due to lacking of β-sheet formation.
76
  
Assembly of cationic surfactant-like peptides was also examined.
73,77,78
 
Hamley et al. observed that A6R formed 3-nm thick sheets at low concentration (2 
wt%), and helical ribbons and nanotubes at high concentration (15 wt% and 
above).
77
 In addition, A12R2 at low concentration assembled into fibrils with a 
small size of 5-6 nm, which turned into mat-like structures at high concentration 
and might be useful in antimicrobial coatings.
78
 Cenker et al. examined AnK (n = 
4, 6, 8 and 10) and found their solubility in water decreased by an order of 
magnitude with increasing every additional alanine residue. A4K was highly 
soluble in water and did not show any morphology, whereas A6K formed hollow 
nanotubes, both A8K and A10K formed thin rod-like aggregates.
79
  
A few studies were reported on the applications of surfactant-like peptides. 
Based on the interfacial adsorption of cationic peptides V3K, V6K and V6K2, Pan 
et al. showed deoxyribonucleic acid (DNA) could be immobilized onto adsorbed 
peptide molecules. Moreover, the increase of hydrophobic chain length led to a 




reduction in CAC and an increase in adsorption amount,
80
 which were also 
observed in CAC of G6K, A6K and V6K at concentration ranging from 4 to 0.15 
mM.
81
 Surfactant-like peptides such as A3K, A6K and A9K were studied for their 
antibacterial activities against Gram-positive and Gram-negative bacteria. The 
increase of hydrophobic tail length resulted in an increase of killing activity of 
both bacteria.
17
 A similar cationic peptide A6R with arginine as hydrophilic head 
showed antimicrobial activity during the interaction of zwitterionic lipid vesicle.
82
 
Qiu et al. designed a three residue AGD, which formed a nano ring structure in 
nonpolar solvent and the ring could be utilized as potential carrier for hydrophilic 
drugs.
83
 Due to structural difference between leucine and isoleucine, Lu and 
coworkers revealed that L3K formed spherical nanospheres, while I3K assembled 
into nanotubes with a diameter of 10 nm. The stable I3K nanotubes were utilized 
as templates to fabricate silica nanotubes.
84,85,86
 Separately, the assembled 
morphologies of A6K (nanotubes) and V6K (lamellar nanostructures) were applied 
by Wang et al. as organic templates for biosilicification.
87
 Short surfactant-like 
peptides were studied in the stabilization of membrane protein, e.g., A6D and A6K 
showed to stabilize G-protein coupled receptor bovine rhodopsin against thermal 
denaturing by surrounding.
28,88
 Furthermore, Ac-A6K-CONH2, KA6 - CONH2, 
Ac-A6D-COOH and DA6-COOH were tested for vesicular based drug delivery of 
model hydrophobic and hydrophilic compounds.
89
 Most studies on surfactant-like 
peptides are summarized in Table 2.1. 
 
 




Table 2.1. Surfactant-like peptides. 
Peptide Sequence Nature of Study Reference 










A6K, V6K, V6H, KV6, 
H2V6, V6K2, L6K2 
Formation of nanostructures 




GAIVLRR Formation of nano donut  Khoe et al.
38
 
Ac-A6D-OH, Ac-A6K-NH2 Synergistic effect of mixing 




A6D, A6K Nanotube formation and CAC 
determination 









I6K2, L6K2, V6K2 Effect of monomer secondary 









A6K, A9K Effect of hydrophobic chain 




A6K Nanotube formation Bucak et al.
72
 
I3K, LI2K, L3K, L4K, L5K, 
I4K, I5K 
Effect of hydrophobicity and 















A6R, A12R2 Fibrils formation Hamley et al.
77,78
 
A4K, A6K, A8K, A10K Assembly Cenker et al.
79
 
V3K,V6K, V6K2 Interfacial adsorption 









G6K, A6K, V6K Effect of hydrophobicity on 





A3K, A6K, A9K, A12K, 
A9K2 
Antimicrobial activity Chen et al.
90,91
 
A6R Antimicrobial activity Dehsorkhi et al.
82
 
AGD Nano ring formation Qiu et al.
83
 









2.2 Lipid-Based Peptides 
Lipid-based peptides consist of lipid chains (Cn, where n represents the number of 
carbon atoms), which are connected with amino acids and act as hydrophobic tail. 
Among the studies listed in Table 2.2, Stupp and co-workers extensively reported 
the assembly of lipid-based peptides.
92-99
 They designed a series of 12 peptide 
amphiphiles to investigate the effects of hydrophobic tail length, polymerizable 
region and end terminal. Control of pH and addition of ions seemed to induce the 
hydrogelation of fibril networks.
92
 Mixing peptide amphiphiles of opposite 
charges promoted assembly because of attractive electrostatic forces between 
them, which led to a nanofiber of 7 nm in diameter and several microns in 
length.
93
 Compared to linear counterparts, branched peptide amphiphiles showed 
higher mobility and were utilized for bearing biological cell adhesion epitope like 
RGDS.
96
 They also conducted molecular dynamics simulations to examine the 
balance between hydrophobic interactions among alkyl tails and hydrogen 




bonding among peptide bonds, and provided a phase diagram for morphological 
transition. A micelle was observed to form with pure hydrophobic interactions, 
whereas a transition to fiber occurred with dominant hydrogen bonding.
97
 A short 
peptide amphiphile (C16 – VEVE) with alternating hydrophobic and hydrophilic 
residues exhibited to form nano belts with a width of 150 nm and a length up to 
0.1 mm. Nevertheless, attaching bioactive epitope (C16 – VEVERGD) led to 
twisted nanoribbons.
98
 Through systematic variation of valine and alanine 
residues in a β-sheet forming epitope of peptide amphiphile (C16 – V3A3E3), the 
mechanical stiffness was found to increase with more valine residues as the 
enhanced hydrogen bond alignment near hydrophobic core.
100
 Furthermore, the 
transition from twisted ribbons to helical ribbons was observed for an amphiphile 
(C16 – F3E3) over four weeks aging. The replacement of phenylalanine by alanine 




Lowik et al. studied the effect of alkyl chain length on secondary structure 
formation and thermal stability of peptide amphiphile Cn – GANPNAAG (n = 4, 
8, 10, 12, 14 and 16). Though depending on temperature, the increase in alkyl 
chain length showed changing of β-sheets to random coil.102 A similar study by 
Meijer et al. was reported on peptide KTVIIE, whose thermal stability was 
enhanced but fibril morphology was not affected by increasing alkyl chain length 
(C6 to C16).
103
 For amphiphile with sequence C12 – EVHHQKL, Deng et al. found 
it displayed a low CMC due to strong aggregation at acidic pH. The morphology 
changed from fibril with 5 nm in diameter at low concentration and low pH to 




taped and twisted fibril with 11 nm in thickness at high concentration and pH.
104
 
Jun et al. demonstrated that the nanofiber network of C16 – GTAGLIGQERGDS 
could be tuned by the peptide length, the addition of divalent cations and the 
mixing of different amphiphiles. Moreover, the presence of RGDS increased the 
cell proliferation and expression of MMP2 enzyme.
105
 Similarly, Meng et al. 
found an increase in α-helical content and morphology changing from nanofibers 
to nanovesicles with increasing peptide length; furthermore, the addition of ions 
resulted in the coexistence of fibers and micelles, indicating the importance of 
electrostatic interactions along with hydrophobic interactions.
106
 The secondary 
structure of amphiphile plays a significant role in assembled morphology. Tirrell 
and coworkers demonstrated that C16 – W(A4K)3A with a combination of α-helical 
and random coil initially formed micelles; however, worm-like micelles were 
formed later because the secondary structure changed to β-sheets.107,108 Fibrous 
networks were observed by Jin et al. in VRGDV and ERGDE attached to C11 and 
C12 lipid chains at acidic pH, and they transited to micelles and vesicles at basic 
pH.
109
 Upon mixing two peptide amphiphiles (C16 – ETTES and C16 – KTTKS) 
with opposite charges, Hamley et al. found cloudy hydrogels with large fibrillar 




Peptide amphiphiles have been studied in various applications such as 
templates for nano fabrication, medical and cosmetic applications. Yuwono et al. 
used a series of C16 – AmX4 (where m = 4, 8, 12 and X = K, H, E) for 
polymerization of tetraethoxysilane.
111
 Stupp’s group studied the encapsulation 




and growth of neural progenitor cells in the fibrous network of C16 – 
A4G3EIKVAV,
112
 which was also attempted to treat a spinal cord injury.
113
 A 
binary combination of positively charged C16 – V3A3K3RGDS and negatively 
charged C16 – V3A3E3 was found to promote cell adhesion, viability and 
proliferation of bone marrow.
114
 Amphiphiles containing RGDS in branched head 
groups showed good performance as certain tissue scaffolds.
115
 Few amphiphiles 
have been applied in skin care applications. Matrixyl is a known commercial 
product derived by C16 – KTTKS, which is effective against wrinkles.
43
 Other 
peptides C16 – GHK and C16 – GQPR, effective to drive new cells growth and 
reduce inflammation, are also utilized in skin care products.
44,45
 Peptides 
conjugated with lipid chains show increased antimicrobial activity compared to 
unconjugated counterparts. By conjugating C12 chain to three peptides, Chu-Kung 
et al. observed different antimicrobial activities based on the α-helical content of 
peptide.
31
 For di- and tri-cationic amphiphiles (C16 – K2, C16 – KXK, X = A, G, K, 
L), Makovitzki et al. found di-amphiphile had the minimal antimicrobial activity 
against Gram-positive, Gram-negative bacteria and fungi, while C16 – KKK and 
C16 – KGK were the most effective.
116
 
Few simulation studies were performed on the interactions and assembly of 
peptide amphiphiles. Starting from a predefined configuration, Schatz and 
coworkers carried out a 40 ns atomistic simulation to examine a cylindrical 
nanofiber composed of 144 peptide amphiphiles (C16 – SLSLAAAEIKVAV). The 
fiber had a radius of 4.4 nm and was stabilized by the electrostatic interactions 
between peptides and sodium ions, as well as the van der Waals interactions 






 The same amphiphile was further simulated by coarse-
grained method from a random configuration. Nine simulations each with a 16 µs 
duration resulted in fiber formation. Micelles were initially formed, then  
aggregated into a three-dimensional network, and further merged into a fiber with 
a radius of 4 nm.
118
 By energy analysis on fiber formation, they concluded that the 
assembly process was enthalpy driven and the solvent electrostatic interaction was 
dominant (54%) in the total driving force for bound state.
119
 The coarse-grained 
simulation also revealed the formation of pillar-like intermediates before forming 
final fiber.
120
 In summary, most peptide amphiphiles tend to assemble into fibrous 
network because of dominant β-sheet structure formation with adjacent 
amphiphiles.  
Table 2.2. Lipid-based peptides 
Sequence Nature of Study Reference 
Cn – C4G3S – RGD,  
n = 6, 10, 16, 22 
Cm – A4G3S – RGD, 
m = 10, 16 
C16 – C4G3S- X, 
X = KGE, RGDS,IKVAV 
Effect of alkyl tail length, 





C16 – A4G3 – X, 
X = EIKVAV, KYIGSR 
C16 – C4G3 – Y 
Y = SRGDS, IKVAV 
Mixing of opposite charged 
amphiphiles and resulting 




C16 – VEVE  
C16 - VEVERGD 
Nanobelt formation Cui et al.
98
 





C16 - V3A3E3, C16 - V2A2E3, 
C16 – V4A4E3,C16 - V2A4E3 
Effect of peptide sequence 








C16 – V4A2E3,C16 – A3V3E3 alignment and hydrogel 
stiffness 





Cn – GANPNAAG, n = 4, 
8, 10, 12, 14, 16 
Effect of alkyl chain length 
on secondary structure and 




Cn – KTVIIE, n = 6, 8, 10, 
12, 14, 16 
Effect of alkyl chain length 




C16 – W(A4K)3A Effect of secondary 





Cn -  VRGDV, n = 11 or 12 
Cm – ERGDE, m = 12 
Effect of pH on assembly Jin et al.
109
 
C16 – AmX4, m = 4, 8, 12 
X = K, H, E 
Templates for nano 





C16 – A4G3EIKVAV Spinal cord injury treatment 









C12 – YGAA(K2A2KA2)2 
C12 – KLFKRHLKWKII 
C12 – YG(AKAKAAKA)2 





C16 – K2,  
C16 – KXK, X = A, G, K, L 








2.3 Amphiphilic Peptides 
Amphiphilic peptides consist of both hydrophobic and hydrophilic amino acid 
residues. Most studies (Table 2.3) have been focused on multi-block amphiphilic 
peptides for their self-assembly and applications in drug and gene delivery. Van 
Hell et al. observed the CAC of Ac-A2V2L3WE2/7-COOH increased with 
increasing glutamic acid ratio. Vesicles were formed with a radius of 60 nm, 
exhibited size expansion and contraction on acidification and neutralization, and 




could load hydrophilic fluorescent molecule calcein. By varying hydrophilic 
block length, the morphology remained nearly same.
121
 Further, the vesicles were 
stabilized by replacing hydrophobic residues with cysteines due to disulfide bond 
formation.
122
 From both experiment and simulation, Van Hell et al. concluded that 
the hydrogen bonds between peptide backbone and water also contributed to the 
stability of vesicles apart from the hydrophobic forces.
123
  
Choi et al. studied the topology effect on assembly for linear and cyclic 
molecules of an identical peptide. Despite of similar CAC and cytotoxicity 
profiles, the peptides differ in final morphology (irregular for linear versus regular 
spherical for cyclic) and thermal stability.
124
 Ghadiri and coworkers showed the 
cyclic peptide (AEAQ)2 formed tubular structures of several nanometers long and 
0.7 to 0.8 nm in diameter.
125
 For another cyclic peptide (WL)3QL, they found the 
formation of transmembrane ion channels through which various drug molecules 
could be transported to living cells.
126
 In addition, various cyclic peptides with a 
common WLWLW sequence were tested as antimicrobial agents against both 
Gram-positive and Gram-negative bacteria.
127
 
Alternating hydrophobic and hydrophilic residues in a peptide tend to form β-
sheet structure. This was observed by Zhang et al. in (AEAEAKAKAK)2 almost 
two decades back. The peptide formed a membrane type structures by the 
complementary ionic bonding between glutamic acid and lysine side chains.
128
 A 
similar peptide (KLDL)3 formed hydrogel and was utilized in cartilage repair as 
scaffold.
129
 They also designed peptides (RADA)4 and (RARADADA)2 tested as 
scaffolds for neurite outgrowth.
130
 




Yang’s group systematically investigated cationic amphiphilic peptides with a 
focus on drug and gene deliveries. Specifically, cholesterol conjugated peptides 
HR15 and HR20 (H5R10 and H10R10) were examined as gene delivery vectors 
based on the formation of cationic charged micelles, which were able to bind 
DNA effectively and resulted in high gene transfection efficiency. Moreover, the 
increment of histidine residues stimulated more gene expression level.
40
  Micellar 
aggregates were also observed in AK27 (A12H5K10) and AK32 (A12H5K15), 
though the latter formed smaller micelles possibly due to hydrophilic repulsion by 
a greater number of lysine side chains. By forming micelles, the hydrophilic 
blocks could localize cationic charges and effectively bind DNA.
41
 Upon 
substituting six alanine residues in AK32 by more hydrophobic phenylalanine 
residues, FA32 (Ac-(AF)6H5K15) showed much smaller CMC (0.042 mg/ml) and 
more compact micelles (110 nm). FA32 had effective loading and controlled 
release of DOX and uptake by cells, and further the co-delivery of drug and gene 
demonstrating synergistic effect on improving HepG2 cells compared to free 
DOX or FA32 micelle-p53 encoding plasmid.
14
 In another study, different 
combinations of alanine and phenylalanine in FA32 (while keeping the same 
hydrophilic chain) were synthesized to examine the effect of hydrophobicity on 
self-assembly, drug loading and gene expression efficiency. The hydrophobic 
combinations were A12H5K15, (A5F)2H5K15, (A3F)3H5K15, (AF)6H5K15 and 
(AL)6H5K15, and the increase of hydrophobicity was found to decrease the CMC 
and size of micelles. FA32 derived micelles also exhibited control release of PTX 
(40% of encapsulated drug in 60 hours), high gene expression efficiency, and 




simultaneous delivery of drug and gene delivery.
39
 All these advantages suggest 
that FA32 is a promising delivery vehicle for both drug and gene simultaneously. 
In addition, Yang’s group designed multi-block peptides based on eight arginine 
residues (X5H4R8, where X = I, F and W), which showed better gene expression 
compared to AK27 and AK32.
131
   
Table 2.3. Amphiphilic peptides 
Peptide Nature of study Reference 
Ac-A2V2L3WE2-COOH 
Ac-A2V2L3WE7-COOH 
Effect of hydrophilic chain 
length on CAC and 
morphology 





Stabilization of vesicles by 
adding cysteine residue. 





Linear and cyclic effect on 












(AEAEAKAK)2 Membrane formation Zhang et al.
128
 
(KLDL)3 Hydrogel formation and 































NH2 - X5H4R8 - CONH2, 
X = I, F, W 
Effect of hydrophobicity 









As discussed above, a large number of experimental studies have been reported to 
explore the self-assembly of peptides and specific applications. Microscopic 
insights are indispensable for elucidating self-assembly at a molecular level. 
However, few simulation/modeling studies have been conducted, and there is a 
gap between fundamental understanding in the self-assembly of peptides and 
practical applications. Consequently, clear knowledge is expected to be obtained 
from the proposed research towards the quantitative understanding of self-
assembly of peptides, which could facilitate the design of new peptides.  
 




Chapter 3. Simulation Methodology 
Self-assembly is a long time scale phenomenon, usually in the order of several 
microseconds or longer. While computationally feasible in submicron scale, 
atomistic simulation is currently not ideal to examine self-assembly, particularly 
for large systems. With this regard, coarse-grained (CG) simulation would be 
more appropriate, in which the number of degrees of freedom is reduced and the 
simulation can be accelerated by several orders of magnitude. Several CG models 







 etc. Recently, Marrink and co-workers developed a CG model 
(MARTINI) for lipids, surfactants with few CG bead types,
135,136
 and was then 
extended to proteins with more classifications of bead types.
137
 The grouping in 
the MARTINI model reduces the number of atoms in simulation and increases the 
time scale by 3 to 4-fold compared to atomistic simulation. It has been 





 etc. In this project, the MARNITI model is used 
to describe peptides and drugs.  
3.1 MARTINI Model  
On average, the MARTINI model uses four to one mapping, i.e., four heavy 
atoms/molecules are collectively mimicked as a single bead for linear molecules. 
In addition, 2-3:1 mapping is applied for cyclic compounds as they require higher 
and closer resolution. Four types of interaction sites are considered, namely polar 
(P), nonpolar (N), apolar (C) and charged (Q). The mass of each type of bead is 




72 a.m.u for regular beads and for 45 a.m.u for beads of cyclic compounds such 
as benzene, phenol, etc. Within the four types, subtypes are further divided by a 
letter denoting (hydrogen bonding capabilities, d = donor, a = acceptor, da = both 
and O = none), number denoting (degree of polarity, from 1 being lowest polarity 
to 5 being highest polarity). This classification introduces a wide variety of bead 
types and allows for flexible discrimination between all amino acids. Figure 3.1 
illustrates the CG structures of 20 amino acids based on the MARTINI model.  
 




The interactions between different types of beads contain non-bonded and bonded 
terms. The non-bonded term includes Lenard-Jones (ULJ) and electrostatic 
interactions (Uel) potentials, while the bonded term includes bond (Ub), angle (Ua) 
and dihedral (Ud and Uid) potentials. All potentials are mathematically expressed 
in equations 3.1 to 3.6. 
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                               (3.1) 
The LJ potential is used to describe van der Waals interaction, and divided into 
ten levels based on the CG bead types. Table 3.1 lists the LJ interaction matrix 
with corresponding parameters of σ and ε in Table 3.2. The interaction between 
charged groups (Q) is described by electrostatic potential with a relative dielectric 









                                              (3.2) 
 





da d a 0 5 4 3 2 1 da d a 0 5 4 3 2 1
da O O O II O O O I I I I I IV V VI VII IX IX
d O I O II O O O I I I III I IV V VI VII IX IX
a O O I II O O O I I I I III IV V VI VII IX IX
0 II II II IV I O I II III III III III IV V VI VII IX IX
5 O O O I O O O O O I I I IV V VI VI VII VIII
4 O O O O O I I II II III III III IV V VI VI VII VIII
3 O O O I O I I II II II II II IV IV V V VI VII
2 I I I II O II II II II II II II III IV IV V VI VII
1 I I I III O II II II II II II II III IV IV IV V VI
da I I I III I III II II II II II II IV IV V VI VI VI
d I III I III I III II II II II III II IV IV V VI VI VI
a I I III III I III II II II II II III IV IV V VI VI VI
0 IV IV IV IV IV IV IV III III IV IV IV IV IV IV IV V VI
5 V V V V V V IV IV IV IV IV IV IV IV IV IV V V
4 VI VI VI VI VI VI V IV IV V V V IV IV IV IV V V
3 VII VII VII VII VI VI V V IV VI VI VI IV IV IV IV IV IV
2 IX IX IX IX VII VII VI VI V VI VI VI V V V IV IV IV











Table 3.2. Parameters σ and ε of LJ potential in the MARTINI model.136 
  ε (kJ/mol) σ (nm) 
O 5.6 0.47 
I 5 0.47 
II 4.5 0.47 
III 4 0.47 
IV 3.5 0.47 
V 3.1 0.47 
VI 2.7 0.47 
VII 2.3 0.47 
VIII 2 0.47 
IX 2 0.62 
 
The bonded interactions between beads i, j, k and l with equilibrium distance db, 
angle φa and dihedral angles ψd and ψid  are described by 
21U ( )
2
b b ij bK d d                                            (3.3) 
21U [cos( ) cos( )]
2
a a ijk aK                                (3.4) 
U [1 cos( )]d d ijkl dK n                                 (3.5) 
2U ( )id id ijkl idK                                       (3.6) 
The parameters in equations 3.3 to 3.6 have following values. The db varies from 




 depending on 
the type of bond. The angle parameters Ka varies from 25 – 50 KJ mol
-1
 and φa 




varies from 100º to 180º. The improper dihedral potential force constant Kid has 




 and equilibrium angle ψid has 0º.
136
 
3.2 Molecular Dynamics Simulation 
Molecular dynamics (MD) simulation method has been utilized in several 
thousands of articles every year.
138,139
 In MD method, the Newton’s equations of 
motion are integrated to find the positions and velocities of particles with respect 
to time. For a system of N atoms, the force Fi on atom i is expressed in terms of 








                                                            (3.7) 
The velocity and acceleration from the Newton’s second law of motion can be 















v                                                           (3.9) 
where mi, ri, vi, ai are mass, position, velocity and acceleration of the i
th
 atom, 
respectively. The above equations 3.8 and 3.9 are solved numerically with a small 
time step to estimate the new positions and velocities. At the new positions, the 
forces are calculated using equation 3.7. These equations are repeatedly solved for 
the next time step. The Verlet algorithm is one of the most common used to 
integrate the above equations.
140
 Other alternatives are velocity Verlet and Verlet 




leap-frog. The Verlet leap-frog algorithm utilizes the positions at time t and 
velocities at t-∆t/2 to update the positions and velocities at a time interval ∆t. The 
algorithm is represented by the following set of equations 
( / 2) ( / 2) ( )i i i
t
t t t t t
m

   v v F
                       
(3.10)
 




( ) [ ( / 2) ( / 2)]
2
i i it t t t t   v v v                          (3.12)  
MD simulation can be usually conducted in various ensembles, such as 
microcanonical (NVE), canonical (NVT) and isobaric-isothermal (NPT). In this 
thesis, all MD simulations are performed in NPT ensemble at body temperature 
and ambient pressure.  
 




Chapter 4. Self-Assembly of Short Amphiphilic Peptides 
FmDn and FmKn 
4.1 Introduction 
Amphiphiles can spontaneously self-assemble into a wide range of morphologies 
such as micelles, fibers, vesicles and sheets.
97,119,141,142
 They have been commonly 
used in cosmetics, nano-fabrication, drug delivery and other applications.
143,144
 
Among various amphiphiles, biocompatible and biodegradable peptides are of 
particular interest. Compared with other materials, peptides display a high level of 
biological and chemical diversity. The assembled peptide structures can be readily 
tuned by tailoring the sequence, length and other conditions.
145
  
A number of experimental and simulation studies have been reported on the 
self-assembly of short peptides. Notably, Zhang and coworkers examined 
surfactant-like peptides such as A6D, V6D, V6D2 and L6D2, which assembled into 
nanotubes and nanovesicles with an average diameter of 30 to 50 nm.
64
 For A3K, 
A6K and A9K, Xu et al. revealed that the morphologies changed from nanosheets 
to nanofibers upon increasing hydrophobic residues.
70
 With more hydrophilic 
residues in A6Kn, V6Kn and L6Kn (n = 1 to 5), vesicles were found to shift into 
nanotubes by Meng et al.
146
 In a series of DxFy peptides, Siddique et al. observed 
micellar formation at larger x (more hydrophilic) and polymeric aggregation at 
larger y (more hydrophobic).
147
 Recently, Wang et al. investigated the assembly 
of I3K, which formed well-ordered nanotubes and showed effective encapsulation 
and sustained release of model drugs.
148
  




On the other hand, molecular simulation studies have been also conducted on 
the self-assembly of short peptides. Simulation can provide important microscopic 
insights into the underlying mechanism of self-assembly and facilitate the rational 
development of new peptides towards desired morphologies. By using CG 
models, Frederix et al. simulated about 400 dipeptide combinations to screen 
possible dipeptides assembling into typical morphologies.
149
 Guo et al. found that 
diphenylalanine could form ordered structures like nanovesicles and further 
turned into nanotubes by vesicle fusion,
15
 but triphenylalanine assembled into 
nanospheres and fully packed nanorods without any voids.
150
 Combining 
simulation and experimental techniques, Hauser et al. examined the assembly of 
tri- to hexa-peptides into coiled fibers.20 The above studies highlight the central 
importance of the type and length of hydrophobic and hydrophilic residues in the 
self-assembly of short peptides. It remains a challenge to quantitatively 
understand the mechanism of self-assembly and the dynamic process of 
morphology transition. However, such understanding is indispensable to tailor 
assembled morphology for specific application. 
In this Chapter, MD simulations were performed to examine self-assembly of 
a series of short peptides FmKn and FmDn. The peptides contain phenylalanine 
(Phe, F), which is rather hydrophobic with a hydropathy index of 2.8.151 It has a 
larger steric volume compared with other hydrophobic amino acids (e.g. A, V, L 
and I). Additionally, two type of hydrophilic residues, lysine (Lys, K) and aspartic 
acid (Asp, D) are present in these peptides. Following this introduction, the 
simulation models and methods are described in Section 4.2. In Section 4.3, the 




simulation results of FmK and FmD (m = 1 to 4) are first presented to examine 
how the type of hydrophilic residues and the length of hydrophobic residues affect 
self-assembly. Then, the results of F3Kn and F6Kn (n = 2 to 12) are presented to 
investigate the effect of the length of hydrophilic residues. The dynamic process 
and microscopic structures are analyzed in terms of the number of clusters, size 
distribution, the radii of micelle, core and shell, and the density profiles of 
residues. Finally, the concluding remarks are summarized in Section 4.4.  
4.2 Models and Methods 
Figure 4.1(a-c) illustrate the atomistic models of three types of residues Phe, Asp 
and Lys. Self-assembly usually occurs in a microsecond time scale or even 
longer.
152,153
 It is thus computationally expensive to conduct atomistic simulation 
for self-assembly process. As an alternative, CG simulation is adopted. In CG 
modeling, the number of degrees of freedom is reduced by mapping a group of 
atoms or molecules into a virtual interaction site. Although the atomistic details 
are lost, the essential molecular features are maintained in CG mapping. 
Consequently, the simulation time scale can be prolonged. Here, FmKn and FmDn 
peptides are represented by the MARTINI force field as described in Chapter 3. 
Figure 4.1(d-f) show the CG models of Phe, Asp and Lys. Figures 4.2 and 4.3 
illustrate the atomistic and corresponding CG representations for all the peptides 
examined in this Chapter. Table 4.1 lists the simulation conditions, including the 
number of peptides, box size, peptide concentration, and simulation duration. 
 




     
 
                                                         
 
Figure 4.1. Atomistic and coarse-grained models of Phe (a, d), Asp (b, e) and Lys 
(c, f), respectively. Color codes for (a), (b) and (c): N, blue; O, red; C, cyan and 
H, white. 
 
Each simulation system contained a certain number of peptides solvated in 
water. All peptides were assumed to be in random-coil conformations. To 
neutralize, chlorine (Cl

) ions and sodium (Na
+
) ions were added for FmKn and 
FmDn, respectively. Water and ions were also represented by the MARTINI force 
field. The simulation box was 11 nm for FmK, FmD and F3Kn, but increased to 15 
nm for F6Kn with relatively longer chains. The concentrations of all peptides were 
approximately the same, equal to 75 mg mL
1
.  
(a)                                      (b)                                                        (c) 
  (d)                                                 (e)                                                    (f) 




       
 




   
 
   
 
   
Figure 4.2. Atomistic representations of peptides FmDn and FmKn. N: blue, O: red, 
C: cyan, and H: white. 
    FD                      F2D                               F3D                             F4D  
          FK                      F2K                         F3K                              F4K  
            F3K2                                     F3K3                                     F3K4      
             F3K5                                F3K6                                    F3K8       
             F6K4                               F6K6                                F6K8              
      F6K10                                                        F6K12   




       
 
      
 




     
 
    
 
Figure 4.3. CG representations of FmDn and FmKn peptides using the MARTINI 
model. F: yellow, D and K: red. 
    FD                      F2D                       F3D                             F4D  
FK                   F2K                         F3K                            F4K  
            F3K2                         F3K3                                        F3K4      
             F3K5                          F3K6                                    F3K8       
             F6K4                            F6K6                                  F6K8              
      F6K10                                                 F6K12   
















FD 171 11 74.87 2500 
FK 142 11 74.93 2500 
F2D 108 11 75.17 2500 
F2K 95 11 74.66 2500 
F3D 79 11 75.38 2500 
F3K 72 11 75.17 2500 
F4D 62 11 75.17 2500 
F4K 58 11 75.53 2500 
F3K2 58 11 76.18 2500 
F3K3 48 11 75.98 2500 
F3K4 41 11 75.94 2500 
F3K5 36 11 76.39 2500 
F3K6 31 11 74.13 2500 
F3K8 26 11 76.18 2500 
F6K4 72 15 74.59 5000 
F6K6 60 15 74.91 5000 
F6K8 51 15 74.51 5000 
F6K10 45 15 75.31 5000 
F6K12 40 15 75.44 5000 
 
The system was initially energy minimized using the steepest descent method 





Then, the peptide positions were restrained and subjected to 2 ns MD simulation 
in NPT (isothermal and isobaric) ensemble to allow water and ions to relax. 
Finally, MD simulation in NPT ensemble was performed 2500 ns for FmK, FmD 
and F3Kn, and 5000 ns for F6Kn. The minimization and MD simulation were 




conducted using GROMACS package (version 4.5.3).
154
 Temperature was kept at 
310 K, i.e., the human body temperature, and controlled by the Berendsen 
method
155
 with a time constant of 1 ps. Pressure was maintained at 1 bar with a 




. The periodic 
boundary conditions were applied in three dimensions. The non-bonded 
Lennard−Jones (LJ) and electrostatic interactions were calculated using a cutoff 
of 1.2 nm. Furthermore, the standard shift function in GROMACS was used to 
reduce undesired noise. Consequently, the LJ potential and electrostatic 
interactions were shifted to zero from 0.9 and 0.0 nm, respectively, to the cutoff 
distance (1.2 nm). A time step of 20 fs was used for integration and trajectory was 
saved for every 1 ns interval. For analysis, the last 1000 ns trajectories were 




4.3 Results and Discussion 
First, FmD and FmK peptides are examined on how hydrophilic residues Asp and 
Lys, as well as the length of hydrophobic residues, affect self-assembly. Then, 
F3Kn and F6Kn peptides with different lengths of hydrophilic Lys residues are 
studied. For both cases, the assembly process and microscopic structures are 
analyzed in terms of the number of clusters, size distribution, radii of micelle, 
core and shell, and density profiles.  




4.3.1 FmD and FmK Peptides  
Figure 4.4 shows the final snapshots for FmD and FmK (m = 1, 2, 3 and 4) at 2500 
ns. Monomers, dimers and loose polymeric clusters are observed for FD and FK, 
whereas all other peptides generally assemble into a single large cluster. Among 
this series of peptides, FD and FK possess the weakest ability in assembly. With 
short hydrophobic block, hydrophobic interaction in FD and FK is not sufficiently 
strong to allow for forming a large cluster. The simulation study by Frederix et al. 
also predicted that FD and FK are difficult to assemble as their aggregation 





Figure 4.4. Final snapshots for FmD and FmK (m = 1, 2, 3 and 4) at 2500 ns. Phe: 
yellow, Asp and Lys: red. Water and ions are not shown for clarity. 
 
F2D, F3D, F4D as well as F2K form sheet-like structures with hydrophobic Phe 
(yellow) pointing inside and hydrophilic Asp/Lys (red) on the surface. 
Nevertheless, F3K and F4K assemble into quasi-spherical micelles. The different 
           FD                            F2D                          F3D                           F4D  
           FK                           F2K                            F3K                        F4K  




assembly capabilities of FmK and FmD are due to the natures of Asp and Lys 
residues. Figure 4.5 illustrates the energy minimized structures of F3K, F4K, F3D 
and F4D. Lys has a positively charged –NH3
+
 group in its side chain. The 
hydrogen atoms in –NH3
+
 tend to form intra-molecular H-bonding with the O and 
N atoms in peptide bond (
|| |
     
O H
C N   ) by bending the side chain. Therefore, the polar 
O and N atoms are embedded inside the molecule. In contrast, the side chain of 
Asp is relatively shorter and cannot easily bend to form intra-molecular H-
bonding. Instead, inter-molecular H-bonds are formed in F3D and F4D, leading to 
the parallel arrangement of peptide chains and sheet-like structures. Comparing 
FmK and FmD, FmK have great potential to form spherical micelles. 
 
Figure 4.5. Energy minimized structures of F3K, F4K, F3D and F4D. 
 
To analyze the dynamic assembly process, Figure 4.6 plots the number of 
clusters (NC) as a function of simulation time for FmD and FmK (m = 2, 3 and 4). 
If any two hydrophobic beads of different peptide chains are within a cutoff 
distance of 0.7 nm, the two peptides are considered to be in the same cluster.  
 
































Figure 4.6. Number of clusters versus time for FmD and FmK (m = 2, 3 and 4). 
 
Initially, NC is equal to the number of peptides added in the system as all 
peptides exist as monomers. For all cases, NC drops dramatically in the first 150 
ns due to the rapid formation of small clusters. Then the small clusters merge into 
larger clusters and finally a stable structure. Eventually, NC approaches 1 for F3D, 
F4D, F3K and F4K. However, NC fluctuates frequently for F2D and F2K, even in 
the last 500 ns simulation as demonstrated in the insets. The fluctuations are due 
to the formation of small clusters, as shown in Figure 4.4, which can merge into 
and separate from the large cluster. Fundamentally, this is because the steric 
volume of hydrophobic F2 is not sufficient to block hydrophilic residues from 
penetrating into hydrophobic core. For F3D, F4D, F3K and F4K, however, the 
stability of assembled cluster is enhanced with increasing the length of 
hydrophobic residues and hence hydrophobic interaction.  
t (ns)






















4.3.2 F3Kn and F6Kn Peptides  
It is also intriguing to elucidate how the length of hydrophilic residues affects 
self-assembly. Figure 4.7 shows the final snapshots for F3Kn (n = 2, 3, 4, 5, 6 and 
8) at 2500 ns.  
       
 
        
 
Figure 4.7. Final snapshots for F3Kn (n = 2, 3, 4, 5, 6 and 8) at 2500 ns. Phe: 
yellow, Lys: red. Water and ions are not shown for clarity. 
 
F3K2 forms a sheet-like cluster with Lys on the surface. Quasi-spherical 
micelles with distinct core/shell are formed for F3K3, F3K4 and F3K5, particularly 
F3K4. Hydrophobic Phe (yellow) constitutes the central core and hydrophilic Lys 
(red) resides in the shell. With further increasing the length of Lys (F3K6 and 
F3K8), micelles still exist but with a smaller size, in addition to the presence of 
monomers and polymeric aggregates. Thus, the assembly capability is reduced as 
the length of hydrophilic residues increases. The reason is that the hydrophobic 
interaction becomes relatively weaker, thus less strong assembly. 
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The assembly process for F3Kn is characterized by the number of clusters NC 
versus time. As shown in Figure 4.8, NC drops dramatically for F3Kn (n = 2, 3, 4, 
5, 6 and 8) in the initial 150 ns due to the rapid formation of small clusters. The 
NC at 2500 ns is approximately equal to 1, 2, 4, 6, 8 and 11, respectively. As 
observed in Figure. 4.7, there is only 1 large cluster formed for F3K2 and the 
cluster is relatively stable with marginal fluctuation in NC. For F3K3 and F3K4, NC 
displays greater fluctuations between 1 and 7. With further increasing the length 
of Lys in F3K5, F3K6 and F3K8, the fluctuations are even greater between 2 and 16 
due to the presence of polymeric aggregates. Obviously, increasing the length of 
Lys leads to weaker assembly.  
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Figure 4.8. Number of clusters versus time for F3Kn (n = 2, 3, 4, 5, 6 and 8). 
 
The micelles formed are composed of hydrophobic core and hydrophilic shell. 
The radii of micelle, core and shell are estimated by
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                                  (4.2) 
where N is the number of peptides in the micelle, rcom is the center-of-mass 
(COM) of the micelle, ri and rHPB,i are the positions of outermost bead and 
hydrophobic bead in each peptide chain. The radius or thickness of shell (Rshell) is 
estimated by  
Rshell = Rmicelle  Rcore                                     (4.3) 
Figure 4.9 plots the radii of micelle, core and shell for F3K2, F3K4 and F3K6. 
With increasing the length of Lys, Rmicelle and Rcore decrease, whereas Rshell 
increases slightly. The trend is accord with the final snapshots in Figure 4.7. As 
discussed above, the assembly capability is reduced and smaller micelles are 
formed for peptides with longer Lys. Similar to Figure 4.8, greater fluctuations 
are also seen here with increasing the length of Lys.  
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Figure 4.9. Radii of micelle (Rmicelle), core (Rcore) and shell (Rshell) for F3K2, F3K4 
and F3K6. 
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Table 4.2 lists the averaged values of Rmicelle, Rcore and Rshell. For F3Kn (n = 2, 
3, 4, 5, 6 and 8), the Rmicelle are 3.05, 2.21, 1.92, 1.75, 1.46 and 1.27 nm and the 
Rcore are 2.59, 1.64, 1.30, 1.11, 0.89 and 0.72 nm, respectively. When the length of 
Lys increases, the size of micelle reduces. Consequently, the number of peptides 
in the micelle drops. 










Rmicelle (nm) Rcore (nm) Rshell (nm) 
F3K2 1 57 ± 1 3.05 ± 0.15 2.59 ± 0.16 0.46 ± 0.04 
F3K3 2 24 ± 4 2.21 ± 0.38 1.64 ± 0.30 0.57 ± 0.11 
F3K4 4 13 ± 3 1.92 ± 0.34 1.30 ± 0.24 0.63 ± 0.12 
F3K5 6 8 ± 2 1.75 ± 0.32 1.11 ± 0.20 0.64 ± 0.14 
F3K6 8 6 ± 4 1.46 ± 0.30 0.89 ± 0.18 0.57 ± 0.14 
F3K8 11 2 ± 1 1.27 ± 0.26 0.72 ± 0.16 0.55 ± 0.13 
F6K4 1 72 4.08 ± 0.06 3.53 ± 0.07 0.56 ± 0.04 
F6K6 2 30 ± 12 3.48 ± 0.15 2.67 ± 0.16 0.81 ± 0.05 
F6K8 3 17 ± 3 3.27 ± 0.05 2.11 ± 0.04 1.16 ± 0.06 
F6K10 4 11 ± 3 3.22 ± 0.14 1.85 ± 0.07 1.37 ± 0.09 
F6K12 4 10 ± 2 3.34 ± 0.26 1.76 ± 0.13 1.58 ± 0.16 
 
The values of radii in Table 4.2 are the averages of all the micelles formed in 
a system. However, various micelles differ in size and fluctuations occur during 
simulation. Thus, a size distribution would give more insightful information about 
the different sizes of micelles. Figure 4.10 shows the distributions of Rmicelle for 
F3Kn (n = 2, 3, 4, 5, 6 and 8). A single peak exists in the distribution for F3K2, 




narrowly ranging from 2.9 to 3.5 nm. This implies the formation of a single large 
cluster as observed in Figure 4.7. For F3K3 and F3K4, there are two peaks 
indicating the presence of two different clusters. The peak centered at 1.0 nm is 
attributed to small clusters, while the other peak between 2.2 - 2.8 nm is due to 
the large clusters. Upon comparison, the distributions for F3K5, F3K6 and F3K8 are 
broader (between 1 to 3 nm). This is because of the weaker assembly capability 
with increasing the length of Lys leads to a wide variety of clusters, including 
monomer, dimer and polymeric aggregates. The distributions are consistent with 
the observation in Figure 4.7. 
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Figure 4.10. Distributions of Rmicelle for F3Kn (n = 2, 3, 4, 5, 6 and 8). 
 
The density profiles of residues versus the distance from the center of mass 
(COM) of a micelle were calculated. As shown in Figure 4.11, the density profiles 
for F3K2, F3K4 and F3K6 are generally similar, i.e., hydrophobic Phe residues 
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reside dominantly in the core. For F3K2, the profile of Phe approaches zero at 4.5 
nm because Phe also exists at the surface of sheet-like micelle (see Figure 4.7). 
However, F3K4 forms quasi-spherical micelle with distinct core/shell structure. 
Specifically, Phe resides in the core (0 – 1.5 nm) and Lys is primarily in the shell 
(1 – 3 nm). With further increasing the length of Lys, Lys also resides in the core 
as seen for F3K6. This is because hydrophobic interaction is weaken, which leads 
to the formation of small micelle and the disruption of core/shell structure. Based 
on the density profiles here and the snapshot in Figure 4.7, F3K4 possesses better 
potential than other F3Kn to form quasi-micelles with distinct core/shell structure. 
Therefore, the optimal ratio of hydrophobic/hydrophilic residues tends to be 3/4.  
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Figure 4.11. Density profiles for F3K2, F3K4 and F3K6. The micelles contain 58, 
10 and 5 peptides, respectively. 
 
We also evaluated the intermolecular LJ and electrostatic interactions between 
peptides for three peptides (F3K, F4K, and F3K2). As shown in Table 4.3, the LJ 
interactions are dominant over the electrostatic counterpart at both free (individual 
peptides) and aggregated states. This is because the interactions in the systems are 
primarily short ranged. Upon changing from free to aggregated state, the LJ and 
electrostatic interactions decrease (more negative), thus promoting the formation 
  F3K2                                 F3K4                                    F3K6  




of clusters. Similar trend was also observed by Yu and Schatz in the simulation 
study of peptide amphiphile.119  
Table 4.3. Interaction energies (kJ/mol) at free and aggregated states. 
Peptide 
Free State Aggregated State 
Electrostatic LJ Electrostatic LJ 
F3K 112.82 4134.99 317.83 14048.97 
F4K 57.79 2137.47 260.06 15244.91 
F3K2 20.80 2425.49 94.08 12779.62 
 
To further explore the effect of the length of Lys, F6Kn (n = 4, 6, 8, 10 and 12) 
were examined. As shown by the final snapshots in Figure 4.12, the number of 
clusters is 1, 2, 3, 4, and 4, respectively.  
 
 
Figure 4.12. Final snapshots for F6Kn (n = 4, 6, 8, 10 and 12) at 5000 ns. Phe: 
yellow, Lys: red. Water and ions are not shown for clarity. 
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F6K4 assembles into an elliptical micelle. With increasing the length of Lys, 
micelles with distinct core/shell are formed. For F6K6, there are two micelles with 
different sizes, while the micelle size is nearly uniform for each of F6K8, F6K10 
and F6K12. Similar to Figure 4.7 for F3Kn, the micelle size reduces when the 
length of Lys increases. Compared with F3Kn, however, fewer monomers are 
present in F6Kn. Apparently, F6Kn have stronger hydrophobic interaction than 
F3Kn and better capability in assembly. 
The number of clusters NC versus time is plotted in Figure 4.13 for F6Kn (n = 
4, 6, 8, 10 and 12). NC remains a relatively stable value after 500 ns for each case. 
This duration (500 ns) is longer than that for F3Kn (150 ns in figure 4.8), due to 
the increased peptide chain length and box size.  
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Figure 4.13. Number of clusters versus time for F6Kn (n = 4, 6, 8, 10 and 12). 
 
Compared with F3Kn, however, F6Kn are more preferential in assembly and NC 
exhibits much smaller fluctuations. Once a cluster is formed, hydrophilic residues 
will not easily move out from the cluster, which however happens more 
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frequently for F3Kn. As also observed in Figure 4.12, NC at equilibrium increases 
from F6K4 to F6K12. This is similar to F3Kn, a consequence of reduced assembly 
upon increasing the length of Lys. 
Figure 4.14 shows the radii of micelle, core and shell for F6K4, F6K8 and 
F6K12. The Rmicelle fluctuates between 4 and 3 nm with increasing the length of 
Lys. Nevertheless, the fluctuations are smaller compared with F3Kn in figure. 4.9. 
The averaged Rmicelle, Rcore and Rshell are listed in Table 4.2. For F6Kn (n = 4, 6, 8, 
10, and 12), the Rmicelle are 4.08, 3.48, 3.27, 3.22 and 3.34 nm, and the Rcore are 
3.53, 2.67, 2.11, 1.85 and 1.76 nm, respectively. Similar to the trend for F3Kn, the 
micelle size reduces when the length of Lys increases.  
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Figure 4.14. Radii of micelle (Rmicelle), core (Rcore) and shell (Rshell) for F6K4, F6K8 
and F6K12. 
 
The distributions of Rmicelle for F6Kn are shown in Figure 4.15. Pronounced 
peaks for F6K4, F6K6 and F6K8 are observed beyond 2.6 nm, indicating no 
presence of monomers. For F6K6, the two peaks suggest two micelles with 
different sizes as seen in Figure 4.12. A major peak is centered at 3.5 nm for 
F6K10 and F6K12, due to the formation of micelles with approximately uniform 
size. Additionally, a minor peak is also observed at 1.5 nm for F6K10 and F6K12. 
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This is attributed to the presence of small clusters (e.g. monomers), as the 
assembly capability is reduced for F6K10 and F6K12. 
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Figure 4.15. Distributions of Rmicelle for F6Kn (n = 4, 6, 8, 10 and 12). 
 
The density profiles for F6K4, F6K8 and F6K12 are shown in Figure 4.16. For 
F6K4, Phe is the dominant residue in whole range, which implies no existence of 
distinct core/shell structure. This is indeed observed in Figure 4.12 that F6K4 
forms an elliptical micelle. For F6K8 and F6K12, distinct core/shell structure is 
seen with Phe in the core (0 – 2 nm) and Lys in the shell (1 – 3.5 nm). Upon 
comparison between F3Kn and F6Kn, the latter forms larger and more stable 
structures due to longer Phe residues. Nevertheless, the optimal ratio of 
hydrophobic/hydrophilic residues seems to be 3/4 for both F3Kn and F6Kn to form 
quasi-spherical micelles. 
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Figure 4.16. Density profiles for F6K4, F6K8 and F6K12. The micelles contain 72, 
16 and 11 peptides, respectively. 
4.4 Conclusions 
We have simulated the self-assembly of a series of short peptides FmDn and FmKn. 
FmKn have stronger capability to form quasi-spherical micelles, while FmDn tend 
to form sheet-like structures. With increasing the length of hydrophilic Lys 
residues in both F3Kn and F6Kn, smaller and less stable micelles are formed with 
larger fluctuations; thus the assembly capability decreases. Compared with F3Kn, 
nevertheless, F6Kn possess more hydrophobic Phe residues and hence stronger 
assembly capability. It can be concluded that hydrophobic interaction plays a key 
role for peptides to assemble.  
Moreover, F3K4 and F6K8 are found to form quasi-spherical micelles with 
distinct core/shell structure (Phe in the core and Lys in the shell). The optimal 
ratio of hydrophobic/hydrophilic residues appears to be 3/4. Upon increasing this 
ratio, quasi-spherical micelles tend to shift to elliptical aggregates; while 
decreasing this ratio leads to smaller and less stable micelles. This ratio found 
here is signifcant as it can assist in the rational selection of appropriate FmKn 
peptides to assemble into spherical micelles. It should be noted, however, this 
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ratio may depend on the type of residue by varying steric volume and 
hydrophobicity, and thus may not be the same for other peptides. Overall, the 
simulation study reported here provides insightful information about the dynamic 
assembly and microsocpic morphology of FmDn and FmKn. With this knowledge, 
different nanostructures could be obtained towards potential applications.  
This Chapter is focused on the molecular level understanding on the self-
assembly of short peptides and the balance between hydrophobic and hydrophilic 
residues. In the next several chapters, relatively longer peptides will be 
considered.  
 




Chapter 5. Self-Assembly of Amphiphilic Peptide 
(AF)6H5K15 
5.1 Introduction 
In Chapter 4, short peptides were simulated for hydrophobic and hydrophilic 
balance. The current chapter is focused on the self-assembly of long peptides. The 
interaction between the drug and carrier materials and their resulting 
morphologies will be important for therapeutic treatment.158 A number of 
materials including polymers and liposomes have been examined as carriers for 
drug delivery because of their self-assembly nature.159 For example, amphiphilic 
polymers with hydrophilic and hydrophobic blocks can form a wide variety of 
morphologies such as micelles, vesicles, tubes, and fibers.24 This is attributed to 
the assembly of hydrophobic blocks, which minimizes the unfavourable 
interactions with water. The morphologies formed can be effectively utilized as 
carriers for controlled and targeted drug delivery.5  
Composed of naturally occurring hydrophilic and hydrophobic amino acids, 
amphiphilic peptides are receiving considerable interest for drug delivery.160 They 
are biodegradable and biocompatible, which are important characteristics for ideal 
drug carriers.161 The assembled structures by peptides are pH-sensitive; 
additionally, the size, stability, and permeability can be fine-tuned by tailoring 
peptide sequence, length, and other solution conditions.145 Experimental studies 
have been conducted to examine the self-assembly of various peptides. By 
varying the composition of V6D2  to V5DVD and V4D2V2, Adams et al. found the 




morphologies changed from nanotubes to fibers and tapes.75 This study suggests 
the critical need in the careful design of peptide sequence and the purification of 
peptide sample, which plays a key role in the observed morphology. Xu et al. 
examined the effect of hydrophobic residues on the assembly of three peptides 
(A3K, A6K, and A9K), and the morphology was found to change from sheets to 
fibers upon increasing hydrophobic segments.162 In a recent study, Wiradharma et 
al. observed the formation of micelles by a peptide namely FA32 [(AF)6H5K15], 
which exhibited simultaneous delivery of drugs and genes.14,39  
A few simulation studies have been reported on the self-assembly of peptides, 
though not so extensive as compared to experimental studies. Hall and coworkers 
simulated the fibril formation of random-coiled polyalanine and the aggregation 
of polyglutamine peptides.163,164 Yethiraj and coworkers examined the  driving 
force for association of peptides and amphiphilic molecules, and demonstrated 
that the driving force is sensitive to conditions.165,166 Combining simulation and 
experimental techniques, Hauser et al. examined the assembly of tri- to hexa-
peptides into coiled fibers.20 Schatz and coworkers simulated the formation of 
fibers from peptide amphiphile (SLSLAAAEIKVAV), which initially assembled 
into micelles and then switched to fibers.117,118 It still remains a challenge on 
quantitative understanding of the self-assembly and morphology transition of 
peptides. Nevertheless, such understanding is indispensable for tuning the 
morphologies formed by peptides and designing specific peptides for efficient 
drug delivery.  




In Chapter 4, the self-assembly of short peptides was simulated. In this 
Chapter, FA32 with 32 amino acid residues is investigated at a microscopic scale. 
As mentioned above, FA32 can assemble into micelle and appears as a promising 
delivery carrier.14,39 Specifically, the assembly of FA32 was experimentally tested 
at concentrations above 40 mg/L, and the micelle formed had a radius of 
approximately 50 nm. For practical application and further development, the 
assembly mechanism of FA32 needs to be better understood from bottom-up. In 
Section 5.2, the simulation models and methods implemented are described. In 
Section 5.3, two sets of simulation results are presented. One set is based on 
different box sizes (11, 15 and 18 nm) but with a close peptide concentration, 
attempting to evaluate the effect of box size. The other set is to examine the effect 
of peptide concentration with different peptides in 18 nm box. A number of 
characteristic parameters such as the number of clusters, the radii of micelle, core 
and shell, and the density profiles of residues are used to analyze the assembly 
process and micellar structure of FA32. Finally, the concluding remarks are 
summarized in Section 5.4.  
 
5.2 Models and Methods 
Figure 5.1(a) illustrates a single chain of FA32, which consists of 32 amino acids 
[(AF)6H5K15]. A and F are hydrophobic alanine (Ala) and phenylalanine (Phe), H 
is amphiphilic histidine (His), and K is hydrophilic lysine (Lys). It is 
computationally very expensive to conduct atomistic simulation for the self-
assembly of such a long peptide, because self-assembly usually occurs in a 




microsecond time scale or even longer.152,153 As an alternative, CG simulation is 






Figure 5.1. (a) Atomistic representation of FA32. N: blue, O: red, C: cyan, and H: 
white. (b) CG representation of FA32 using the MARTINI model. Ala and Phe: 
yellow, His: blue, and Lys: red. (c) Aggregated structure of FA32.  
 
By using the MARTINI model, FA32 is mimicked by 95 beads in single 
chain, as shown in Figure 5.1(b). Nevertheless, the chain shown is in a physically 
unrealistic extended conformation. To examine its conformation in a solution, 
MD simulation was carried out for a single FA32 chain in 11 nm box. 
Specifically, the FA32 chain was solvated in water and electrically neutralized by 
adding Cl

 ions. Both water and Cl








model. Within 100 ns, the extended FA32 chain was folded into an aggregated 
structure as shown in Figure 5.1(c). This aggregated structure was subsequently 
used to build two sets of simulation systems for assembly. As listed in Tables 5.1 
and 5.2, the first set used three different box sizes (Lb = 11, 15, and 18 nm) with a 
close peptide concentration, whereas the second set had nine different peptide 
chains (Np =  12, 18, 24, 30, 36, 42, 48, 54, and 60) in 18 nm box.  
Table 5.1. Three different box sizes. 
No. Lb (nm) Np Cp (mg/mL) 
1 11 10 76.7 
2 15 26 73.1 
3 18 44 78.0 
 
Table 5.2. Nine different peptide concentrations in 18 nm box. 
No. Np Cp (mg/mL) 
1 12 20.7 
2 18 31.2 
3 24 41.9 
4 30 52.5 
5 36 63.4 
6 42 74.3 
7 48 85.5 
8 54 96.5 
9 60 107.5 
 
From these two sets of systems, the effects of box size and peptide 
concentration were separately examined. Energy minimization and MD 
simulations were conducted with the same parameters as used in Chapter 4. A 




time step of 20 fs was used for integration and trajectory was saved for every 200 
ps interval. The simulation duration was 5 µs, which is equivalent to an effective 
time of 20 µs. In the discussion below, we use the actual simulation time rather 
than the effective one unless specifically stated. The average values presented 
were calculated based on the last 1 µs. 
5.3 Results and Discussion 
We first examine the effect of box size and then the effect of peptide 
concentration. For both cases, the assembly process and equilibrium structure are 
characterized by the number of clusters, the radii of micelle, core, and shell, as 
well as the density profiles of residues.  
5.3.1 Effect of Box Size 
The effect of box size is examined by simulation in three boxes with size Lb = 11, 
15 and 18 nm. The peptide concentration in the three cases is close to 75 mg/mL. 
It should be noted that the concentration used in simulation is usually much 
higher than experimentally conducted.
14,39
 The reason is that assembly is a long 
time scale process, and high concentration is often needed to promote the 
occurrence of assembly and reduce thermal noise.
15
 This is similar to our recent 
simulation studies for liquid chromatographic separation of amino acids in a 
protein crystal and a metal-organic framework, respectively, where the external 
force assigned was higher than practically adopted.
167,168
  
Figure 5.2 shows the initial and final snapshots of the three systems with 
different Lb. Water and Cl

 ions are not shown for clarity.  




                            
                     
           
Figure 5.2.  Initial and final snapshots of (a) 10 peptides in an 11 nm box (b) 26 
peptides in a 15 nm box (c) 44 peptides in an 18 nm box. Ala and Phe: yellow, 
His: blue, Lys: red. Water and Cl

 ion are not shown for clarity.  
Obviously, quasi-spherical micelles are formed in all the three systems. 









forms the shell, and amphiphilic His (blue) is located at the interface. At the end 
of simulation, there are 1, 3, and 5 micelles formed in 11, 15, and 18 nm boxes, 
respectively. Thus, the number of micelles is approximately proportional to box 
volume. Table 5.3 lists the number of peptides per micelle. In 11 nm box, the 
micelle contains 10 peptides; in 15 and 18 nm boxes, about 9 peptides exist in 
each micelle.  
Table 5.3. Number of micelles, peptides per micelle, Rmicelle, Rcore, and Rshell in 
three box sizes. 
Lb (nm) 




Rmicelle (nm) Rcore (nm) Rshell (nm) 
11 1 10 3.43 ± 0.12 2.31 ± 0.07 1.11 ± 0.15 
15 3 9 ± 1 3.27 ± 0.08 2.13 ± 0.07 1.14 ± 0.07 
18 5 9 ± 4 3.22 ± 0.05 2.15 ± 0.03 1.07 ± 0.07 
 
To better understand the assembly process, Figure 5.3 shows the snapshots for 
44 peptides in 18 nm box at different time intervals. Initially (0 ns), each peptide 
exists individually in the system. At an early stage of simulation (250 ns), 
neighboring peptides aggregate into small clusters with hydrophobic residues 
residing in the interior. This implies that when hydrophobic residues move close, 
peptide chains start to aggregate and form clusters because of hydrophobic 
interactions. Along with simulation (500 to 1000 ns), small clusters merge into 
large clusters. From 2000 ns till the end of simulation (5000 ns), 5 micelles are 
present and this number remains nearly the same. Therefore, the assembly can be 
considered as a three-step process: aggregation of small clusters, then large 
clusters, and eventually formation of micelles. In the last step, micelles reach 




equilibrium structure and cannot further aggregate even when the hydrophilic 
shells of two micelles come into contact. This might be due to the repulsion 
between positively charged Lys resides, which is unfavorable for micellization. 
Although Figure 5.3 is for 44 peptides in 18 nm box, similar process is also 
observed in the other two boxes (10 peptides in 11 nm box and 26 peptides in 15 
nm box).  
       
 
 
        
 
 
       
Figure 5.3. Snapshots for 44 peptides in 18 nm box at different time intervals.  
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Figure 5.4. Number of clusters versus time for 10, 26 and 44 peptides in 11, 15 
and 18 nm boxes, respectively. 
 
To quantitatively characterize the observed assembly process, two peptide 
chains are classified into the same cluster if the distance between any hydrophobic 
beads of the two chains is less than 0.7 nm. Figure 5.4 shows the number of 
clusters (Nc) as a function of simulation time t in three boxes. At t = 0, Nc is large 
because each peptide exists individually. Nc decreases rapidly within 100 ns in 11 
nm box, and within 400 – 500 ns in 15 and 18 nm boxes. This is attributed to the 
formation of small clusters by peptide chains in the first step. In the second step, 
small clusters merge into large ones and Nc decreases gradually. In the third step, 
micelles are formed and afterwards Nc is nearly constant. Specifically, Nc are 
equal to 1, 3, and 5 in the three boxes, consistent with the number of micelles 
visualized in Figure 5.2. With a closer look, we see small fluctuations of Nc in the 
third step. In 18 nm box, e.g., Nc fluctuates from 5 to 4 during 3000 ~ 3200 ns. 
This corresponds to the occurrence of close contact of two micelles during 




assembly. Despite the fluctuations, the constant value of Nc remains well and thus 
the micelles are stable.  
The micelle formed by FA32 peptide consists of hydrophobic core and 
hydrophilic shell. The radii of micelle, core and shell are estimated using 
equations 4.1 to 4.3 in Chapter 4. Figure 5.5 illustrates the Rmicelle, Rcore, and Rshell 
versus time in three boxes with Lb = 11, 15, and 18 nm. The profiles generally 
remain flat with time, suggesting equilibrium is reached. From the last 1000 ns 
trajectory, the time-averaged values of the Rmicelle, Rcore, and Rshell are listed in 
Table 5.3. The Rmicelle, Rcore, and Rshell are close in the three boxes and in the 
ranges of 3.2 ~ 3.4 nm, 2.1 ~ 2.3 nm, and 1.0 ~ 1.1 nm, respectively. This reveals 
that they are essentially independent of box size, and the small difference among 
the three boxes can be attributed to the slight different number of peptide chains 
present in each micelle. 
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Figure 5.5. Radii of micelle (Rmicelle), core (Rcore) and shell (Rshell) for (a) 10 
peptides in 11 nm box, (b) 26 peptides in 15 nm box, and (c) 44 peptides in 18 nm 
box. 
 
Figure 5.6 shows the distributions of Rmicelle in three boxes with Lb = 11, 15, 
and 18 nm. We should point out that in 11 nm box, only one micelle was observed 
(a) (b) (c) 




in the final snapshot (see Figure 5.2a). However, the side chains of Lys exhibit 
large fluctuations and hence Rmicelle distributes between 3.1 and 3.7 nm. In 15 nm 
box, Rmicelle ranges from 2.8 to 3.7 nm. In 18 nm box, Rmicelle is distributed more 
widely, from 2.4 to 4.0 nm. Thus, the distribution becomes wider with increasing 
box size due to the formation of more micelles and larger fluctuations in micelle 
size. Compared to experimentally measured value (about 50 nm),
14,39
 the 
predicted Rmicelle is much smaller. The possible reasons are (1) the simulation is 
not sufficiently long and prohibits the formation of very larger micelles (2) the 
force field adopted might not be accurate to describe FA32 peptide. It is 
worthwhile to note that similar magnitude of deviation in the size of spherical 
























































Figure 5.6. Distributions of Rmicelle for (a) 10 peptides in 11 nm box (b) 26 
peptides in 15 nm box (c) 44 peptides in 18 nm box.  
FA32 consists of four types of residues including Ala, Phe, His, and Lys. To 
examine their locations in a micelle, the density profiles were evaluated as a 
function of distance from the COM. For the case of 26 peptides in 15 nm box, 3 
micelles are formed and the density profiles are shown in Figure 5.7. Apparently, 
(a)                                              (b)                                               (c) 




the density profiles of 3 micelles are similar, with clear core and shell indicating 
the 3 micelles possess nearly identical structure. Specifically, hydrophobic Ala 
and Phe reside in the core, mostly in the range of 0 to 1.5 nm. In particular, Phe 
has the highest density at the COM. Again, this confirms the observation in figure 
5.2 that the formation of micelle core is due to hydrophobic interactions. 
Hydrophilic Lys is located in the shell, preferentially at 1 ~ 3 nm. For amphiphilic 
His, a pronounced density is observed at 1.5 nm, which is the interface. 
Furthermore, most Cl

 ions are located at 1 ~ 3 nm for the neutralization of Lys. 
The density profiles in 11 and 18 nm boxes exhibit features similar to Figure 5.7. 
Radius (nm)




















































































Figure 5.7. Density profiles of micelles for 26 peptides in 15 nm box. The 
micelles contain 10, 8, and 8 peptides in (a), (b), and (c), respectively. 
From the above simulation results in three boxes with different sizes but a 
close peptide concentration, we can conclude that the number of micelles is 
proportional to box volume, the number of peptides per micelle is approximately 
the same in the three boxes, the Rmicelle, Rcore, and Rshell are nearly identical despite 
different distributions, and the density profiles are also similar. Therefore, the 
assembled structures and microscopic properties are essentially independent of 
box size.  
(a)                                                (b)                                                (c) 




5.3.2 Effect of Peptide Concentration 
Peptide concentration is one important factor to govern assembly. The effect of 
peptide concentration is examined by simulating nine systems with different 
number of peptides Np in 18 nm box, as listed in Table 5.2. From the final 
snapshots illustrated in Figure 5.8, the numbers of micelles formed are estimated 
to be 2, 3, 3, 4, 4, 6, 3, 5, and 5 for Np = 12, 18, 24, 30, 36, 42, 48, 54, and 60 in 
the nine systems, respectively. Apparently, the number of micelles appears to be a 
complex function of Np. With increasing Np from 12 to 42, the number of micelles 
increases from 2 to 6, and the micelles exhibit quasi-spherical shape. However, 
the number decreases to 3 for Np = 48, and then increases again to 5 with further 
increasing Np to 54 and 60. The decrease is due to the formation of elongated 
micelles as more peptides are involved in micellization. It is interesting to note 
that a micelle with more than 15 peptides exhibits irregular non-spherical shape. 
For example, several micelles consist of 20 peptides and are elongated in one 
direction. To quantitatively analyze the effect of peptide concentration, three 
systems with Np = 18, 36, and 60 are chosen and further discussed below.  
 
 
(a) Np = 12 (b) Np = 18 (c) Np = 24 







Figure 5.8. Final snapshots for different peptide concentrations in 18 nm box. 
From (a) to (i), Np = 12, 18, 24, 30, 36, 42, 48, 54, and 60, respectively.  
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18 peptides in 18 nm box
36 peptides in 18 nm box 
60 peptides in 18 nm box 
 
Figure 5.9. Number of clusters for 18, 36, and 60 peptides in 18 nm box. 
Figure 5.9 shows the number of clusters (Nc) for Np = 18, 36, and 60. The 
three-step assembly mechanism discussed above is also observed here. For each 
Np, small clusters are initially aggregated and then merged into large clusters, and 
(d) Np = 30 (e) Np = 36 
(f) Np = 42 
(g) Np = 48 (h) Np = 54 
(i) Np = 60 




finally formed micelles. With increasing Np, the value of Nc increases. 
Specifically, 3 micelles are formed at 1000 ns for Np = 18; while for Np = 36 and 
60, 4 and 5 micelles are formed at about 1500 ns. However, small fluctuations are 
observed afterwards because the micelles may move close or away. Consequently, 
the number of micelles, as well as fluctuations, increases with increasing Np. 
Figure 5.10 plots the radii of micelle (Rmicelle), core (Rcore), and shell (Rshell) for 
Np = 18, 36, and 60. Equilibrium stage is reached for each Np, and the time-
averaged values are listed in Table 5.4. With increasing Np from 18, 36 to 60, the 
Rmicelle, Rcore, and Rshell increase from 2.92 to 3.61 nm, 1.97 to 2.37 nm, and 0.94 to 
1.23 nm, respectively. This is because the micelle contains more peptides for a 
greater Np. As listed in Table 5.4, the number of peptides per micelle increases 
from 6, 9 to 12 upon increasing Np from 18, 36 to 60. 
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Figure 5.10. Radii of micelle (Rmicelle), core (Rcore), and shell (Rshell) for (a) 18, (b) 
36 and (c) 60 peptides in 18 nm box. 
 
Table 5.4. Number of micelles, peptides per micelle, Rmicelle, Rcore, and Rshell in 18 
nm box. 
Np 




Rmicelle (nm) Rcore (nm) Rshell (nm) 
12 2 6 3.12 ± 0.11 2.07 ± 0.08 1.05 ± 0.13 
(c) 
(b) (a) 




18 3 6 2.92 ± 0.06 1.97 ± 0.05 0.94 ± 0.08 
24 3 8 3.13 ± 0.07 2.06 ± 0.07 1.07 ± 0.08 
30 4 7 ± 1 3.18 ± 0.06 2.02 ± 0.03 1.15 ± 0.07 
36 4 9 3.29 ± 0.05 2.17 ± 0.05 1.19 ± 0.05 
42 6 7 3.04 ± 0.09 2.02 ± 0.06 1.03 ± 0.08 
48 3 16 3.48 ± 0.53 2.26 ± 0.35 1.22 ± 0.18 
54 5 11 ± 1 3.55 ± 0.05 2.37 ± 0.04 1.17 ± 0.05 
60 5 12 3.61 ± 0.04 2.37 ± 0.03 1.23 ± 0.04 
 
The distributions of Rmicelle for Np = 18, 36, and 60 are shown in Figure 5.11. 
For Np = 18, the Rmicelle is distributed between 2.3 and 3.4 nm. The distribution is 
in the range of 2.6 and 3.7 nm for Np = 36, 3.3 and 4.0 nm for Np = 60. 
Apparently, the micelle size becomes lager with increasing Np as the micelle 
contains more peptides.  
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Figure 5.11. Distributions of Rmicelle for (a) 18 (b) 36 (c) 60 peptides in 18 nm box.  
Figure 5.12 shows the density profiles of micelles for Np = 18, 36, and 60. The 
three micelles considered contain 7, 10, and 12 peptides, respectively. All the 
density profiles reveal the formation of hydrophobic core and hydrophilic shell. 
For the micelle with 7 peptides, Ala and Phe reside over the range of 0 - 1.5 nm, 
(a)                                              (b)                                                 (c)    




and similar to figure 5.7, Phe exhibits the highest density at the COM. Lys is 
located mostly in the shell beyond 1.5 nm and His is preferentially at the interface 
of about 1.5 nm. As a comparison, the profiles for the micelles with 10 and 12 
peptides are shifted towards right (further away from the COM). This is consistent 
with the observation in figure 5.11, i.e, the micelle size becomes larger with more 
peptides present. 
Radius (nm)



















































































Figure 5.12. Density profiles of micelles for 18, 36, and 60 peptides in 18 nm 
box. The micelles contain 7, 10, and 12 peptides in (a), (b), and (c), respectively. 
 
The simulation results with different peptide concentrations reveal that the 
number of micelles formed is a complex function of peptide concentration. With 
increasing peptide concentration, the micellar shape changes from quasi-spherical 
to elongated, the number of peptides per micelle increases, the Rmicelle, Rcore, and 
Rshell also increase, and the density profiles are extended away from the center of 
micelle.  
5.4 Conclusions 
The self-assembly of amphiphilic peptide FA32 has been investigated using 
coarse-grained simulation. Micelles are observed to form, in which Ala and Phe 
are located in the core, Lys in the shell, and His at the interface. A three-step 
(a)                                                (b)                                               (c)  




process is proposed for the assembly. Initially, peptides aggregate into small 
clusters, then merge into large clusters, and eventually form micelles. Once 
equilibrium is reached, the micelle structure remains relatively stable. The 
interactions between hydrophobic residues are crucial for the aggregation of small 
cluster and subsequent micellization. In three simulation boxes with size of 11, 
15, and 18 nm, quasi-spherical micelles are formed. At a given peptide 
concentration, the number of peptides per micelle remains nearly constant. The 
radii of micelle, core, and shell are approximately the same in the three boxes, 
within 3.2 ~ 3.4 nm, 2.1 ~ 2.3 nm, and 1.0 ~ 1.1 nm, respectively. The density 
profiles of residues in the micelles are also similar. These results reveal that the 
assembled structures are largely independent of box size. In nine systems with 
different peptide concentrations, quasi-spherical micelles are observed to change 
to elongated shape at high concentrations. With increasing concentration, the 
micelle size increases, as well as the radii of micelle, core, and shell.  
It should be noted that the assembly depends on several factors such as system 
size, concentration, chain length, sequence, temperature, pH value, ionic strength, 
etc. While this Chapter is focused on the effects of system size and concentration, 
the next Chapter will examine how the hydrophilic and hydrophobic residues 
affect the self-assembly of FA32 derivatives. 




Chapter 6. Self-Assembly of FA32 Derivatives: Roles of 
Hydrophilic and Hydrophobic Residues  
6.1 Introduction 
The previous chapter examined the effects of box size and peptide concentration 
on the self-assembly of FA32 peptide. In this chapter, the role of chain length will 
be investigated. Self-assembly is an interesting naturally occurring 
phenomenon.
143
 Amphiphilic materials (e.g. polymers, surfactants and peptides) 
have the ability to self-assemble into a wide variety of morphologies such as 
micelles, vesicles, nanotubes, etc.
141,169,170
 Of particular interest are amphiphilic 
peptides. They are biocompatible and the assembled structures can be readily 
tuned by tailoring peptide sequence, length, and other solution conditions.
145
 
Consequently, amphiphilic peptides have been recognized as good candidates for 
drug delivery. 
As pointed out above, the self-assembly of peptides depends on various 
factors including the sequence and length of hydrophilic and hydrophobic 
residues. Adams et al. found the morphology of V6D2 changed from nanotube to 
fiber and tape upon varying the sequence to V5DVD and V4D2V2.
75
 In DxFy series 
of peptides (x and y: between 1 and 3), Siddique et al. demonstrated micellar 
formation for larger x (more hydrophilic) and polymeric aggregation for larger y 
(more hydrophobic).
147
 Lee et al. examined the morphologies of (FKFE)2, 
(FK)2(FE)2, KEF4KE, (KFFE)2 and F2(KE)2F2 at two concentrations (0.2 and 1.0 
µM). Only (FKFE)2 and (FK)2(FE)2 formed nano-ribbon at both concentrations, 




KEF4KE and F2(KE)2F2 formed nanotape and micelle respectively at 1.0 µM; 
however, (KFFE)2 did not assemble at either concentration.
171
 Meng et al. varied 
the number and type of residues in X6Kn (X = alanine, valine, or leucine; K = 
lysine; n = 1−5) and observed that the morphology changed from vesicle to tube 
and ribbon upon increasing hydrophobicity.
146
 By increasing x from 1 to 4 in 
(AEIEALK)x, Marullo et al. found that short peptides exhibited β-sheet structure 




Above studies highlight the significance of tuning the sequence as well as 
length of hydrophilic and hydrophobic residues in morphology. Nevertheless, 
their roles in self-assembly remain largely elusive. Experimental techniques have 
a limitation in pursuing microscopic insight, but the limitation can be overcome 
by employing molecular simulation approach. From simulation, one would 
quantitatively understand the mechanism of self-assembly at a molecular-level 
and thus manipulate the sequence or length of peptides toward desired 
morphology.  
In Chapter 5, the assembly of FA32 peptide was simulated. This chapter is 
focused on the roles of hydrophilic and hydrophobic residues in the assembly of 
FA32 derivatives. In Section 6.2, the simulation models and methods 
implemented are described. The simulation results are presented in Section 6.3 for 
three sets of systems by varying the length of hydrophilic residues, the 
replacement of hydrophobic residues, and the length of hydrophobic residues, 
respectively. The characteristic parameters including the number of clusters, 




radius, and density profile are used to analyze assembly process and equilibrium 
structure. Finally, the concluding remarks are summarized in Section 6.4. 
6.2 Models and Methods 
Three sets of FA32 derivatives are examined by varying the length of hydrophilic 
(Lys) residues, the replacing hydrophobic (Ala and Phe) residues, and the length 
of hydrophobic (Phe) residues. All the peptides were modeled in a CG manner 
using the MARTINI force field. Figure 6.1 illustrates the CG models of the FA32 
derivatives examined.  
All the peptides were assumed to possess random-coil configurations. To 
examine their conformation in a solution, MD simulation was carried out for each 
single peptide chain in 11 nm box. Specifically, each peptide chain was solvated 
in water and electrically neutralized by adding Cl

 ions. Both water and Cl
were 
also represented by the MARTINI model. Within few 100 ns, the extended 
peptide chain was folded into an aggregated structure. This aggregated structure 
was subsequently used to build further simulations. 
Each simulation system contained a cubic box (around 18 nm) with 50 peptide 
chains dissolved in water. Energy minimization and MD simulations were 
conducted with the same parameters as used in Chapter 4. A time step of 20 fs 
was used for integration and trajectory was saved for every 200 ps interval. The 
average values presented were calculated based on the last 1 µs.  





Figure 6.1. Coarse-grained models of FA32 derivatives. Ala and Phe: yellow, 
His: blue, and Lys: red. 




6.3 Results and Discussion 
The roles of hydrophilic and hydrophobic residues in self-assembly are examined 
by varying the length of hydrophilic residues, the replacement of hydrophobic 
residues and length of hydrophobic residues, respectively.  
6.3.1 Length of Hydrophilic Residues 
Four FA32 derivatives (AF)6H5K10, (AF)6H5K15, (AF)6H5K20 and (AF)6H5K25 are 
examined by varying the length of hydrophilic Lys residues. Figure 6.2 illustrates 
their simulation snapshots at different time intervals (0, 250, 1000 and 5000 ns). 
Water and Cl

 ions are not shown for clarity. Self-assembly is observed for all the 
four peptides. Initially, peptides aggregate into small clusters with hydrophobic 
residues residing in the interior; then, small clusters merge into large clusters; 
finally, micelles are formed. The assembly can therefore be considered as a three-
step process: aggregation of small clusters, then large clusters, and formation of 
micelles. At equilibrium (5000 ns), the micelles appear to be rod-like for 
(AF)6H5K10, but quasi-spherical for the other three peptides. In terms of the 
micellar structure, hydrophobic Ala and Phe (yellow) constitute the core, 
hydrophilic Lys (red) resides in the shell, and amphiphilic His (blue) is at the 
core/shell interface. Table 6.1 lists the number of micelles, equal to 2, 5, 9 and 12 
for (AF)6H5K10, (AF)6H5K15, (AF)6H5K20 and (AF)6H5K25. In addition, the size of 
micelles appears to be smaller for peptide with longer Lys residues. We even 
observe individual peptide chains for (AF)6H5K25. Thus, the assembly capability 
is reduced with increasing the length of Lys residues.  





       
 
       
 
        
 
       
Figure 6.2. Snapshots for (AF)6H5K10, (AF)6H5K15, (AF)6H5K20 and (AF)6H5K25 
at different time intervals. Water and Cl

 ions are not shown for clarity. 
(AF)6H5K10 
              0 ns                           250 ns                           1000 ns                         5000 ns 
(AF)6H5K15 
              0 ns                           250 ns                           1000 ns                         5000 ns 
              0 ns                           250 ns                           1000 ns                         5000 ns 
(AF)6H5K20 
              0 ns                           250 ns                           1000 ns                        5000 ns 
(AF)6H5K25 




This is attributed to the increasingly stronger electrostatic repulsion between the 
positively charged Lys residues, which is unfavorable for micellization as 




Figure 6.3 quantitatively plots the number of clusters NC as a function of 
simulation time t. If the distance between any hydrophobic beads from two 
peptide chains is less than 0.7 nm, the two chains are considered to be in the same 
cluster. With increasing time, NC initially decreases rapidly, then slowly, and 
eventually approaches a constant. This is due to the formation of small clusters, 
followed by large cluster and finally micelles. While the general trend of NC ~ t is 
similar, the details are different for (AF)6H5K10, (AF)6H5K15, (AF)6H5K20 and 
(AF)6H5K25. For (AF)6H5K10, small clusters exist till 300 ns and two to three 
micelles start to form at 600 ns. For (AF)6H5K15, the assembly is slower as small 
clusters exist till 1000 ns and five to six micelles are formed at 1000 ns. With 
further increasing the length of Lys residues, the assembly is even slower. For 
(AF)6H5K25, small clusters exist until 2600 ns. For the four peptides, NC at 5000 
ns are approximately equal to 2, 5, 9 and 12, respectively. Despite the fluctuations 
in NC ~ t, it is clear that NC increases with the length of Lys residues. As 
mentioned above, the shells of clusters/micelles primarily consist of Lys, which 
prevents the interactions between hydrophobic Ala and Phe residues. 
Consequently, the assembly capability is reduced with increasing length of Lys 
residues.  







































Figure 6.3. Number of clusters versus time for (AF)6H5K10, (AF)6H5K15, 
(AF)6H5K20 and (AF)6H5K25. 
 
The micelles assembled by the FA32 derivatives are composed of 
hydrophobic core and hydrophilic shell. The radii of micelle and core are 
estimated by equations 4.1 to 4.3 as mentioned in Chapter 4. Figure 6.4 shows the 
Rmicelle, Rcore and Rshell for (AF)6H5K10, (AF)6H5K15, (AF)6H5K20 and (AF)6H5K25 
during the last 1000 ns. While there are fluctuations, the radii remain relatively 
flat, suggesting equilibrium is achieved. From the last 1000 ns trajectory, the 
time-averaged Rmicelle, Rcore and Rshell are listed in Table 6.1. For (AF)6H5K10, 
(AF)6H5K15, (AF)6H5K20 and (AF)6H5K25, the Rmicelle values are approximately 
4.31, 3.35, 3.21 and 2.79 nm; the Rcore are 3.34, 2.26, 1.93 and 1.56 nm. With 
increasing length of Lys residues, therefore, the Rmicelle decreases as seen in Figure 
6.2. This prediction is qualitatively consistent with the experimental observation 
by Wiradharma et al.,
41
 in which the Rmicelle values were measured to be 427 and 
394 nm for A12H5K10 and A12H5K15. 
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Figure 6.4. Radii of micelle (Rmicelle), core (Rcore) and shell (Rshell) for (AF)6H5K10, 
(AF)6H5K15, (AF)6H5K20 and (AF)6H5K25. 
 
However, the simulated Rmicelle here is much smaller. The plausible reasons 
are (1) the simulation is not sufficiently long and prohibits the formation of very 
large micelles (2) the force field adopted might not be accurate to describe FA32 
derivatives (3) the hydrophobic residues between experimental and our theoretical 
studies are different. It is worthwhile to note that similar magnitude of deviation 
in the size of vesicles formed by diphenylalanine was also observed between 
simulation and experimental studies.
15
 
(a) (AF)6H5K10                                                     (b) (AF)6H5K15 
(c) (AF)6H5K20                                                      (d) (AF)6H5K25 













Rmicelle (nm) Rcore (nm) Rshell (nm) 
(AF)6H5K10 2 25 ± 12 4.31 ± 0.25 3.34 ± 0.24 0.97 ± 0.06 
(AF)6H5K15 5 10 ± 5 3.35 ± 0.05 2.26 ± 0.04 1.09 ± 0.05 
(AF)6H5K20 9 5 ± 2 3.21 ± 0.10 1.93 ± 0.06 1.28 ± 0.08 
(AF)6H5K25 12 4 ± 2 2.79 ± 0.23 1.56 ± 0.14 1.23 ± 0.12 
(AF3)3H5K15 5 10 ± 6 3.42 ± 0.04 2.36 ± 0.03 1.06 ± 0.06 
F4H5K15 6 8 ± 4 3.21 ± 0.07 1.47 ± 0.04 1.73 ± 0.07 
F8H5K15 6 8 ± 4 3.21 ± 0.05 1.88 ± 0.03 1.33 ± 0.06 
F12H5K15 4 12 ± 5 3.71 ± 0.11 2.43 ± 0.09 1.28 ± 0.05 
F16H5K15 3 17 ± 6 4.06 ± 0.23 3.05 ± 0.24 1.00 ± 0.05 
 
The Rmicelle discussed above is the ensemble average of all micelles in a 
system. Nevertheless, the system may contain different micelles with various 
sizes. Figure 6.5 shows the distributions of Rmicelle for (AF)6H5K10, (AF)6H5K15, 
(AF)6H5K20 and (AF)6H5K25. The distribution for (AF)6H5K10 is within 2.8 ~ 5.9 
nm, a bit wider compared to (AF)6H5K15 and (AF)6H5K20 because of the 
formation of rod-like micelles and the relatively larger fluctuation in the Rmicelle 
(see Figure 6.4). With increasing length of Lys residues, the micelle size is 
smaller and more uniform, thus the distribution becomes relatively narrower. 
Specifically, the distribution for (AF)6H5K20 is within 2.0 ~ 4.5 nm. For 
(AF)6H5K25, however, the assembly capability is weaker compared to the other 
three peptides; the pronounced peak within 1.5 ~ 2 nm corresponds to the 
presence of individual peptide chains and small clusters. 
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Figure 6.5. Distributions of Rmicelle for (AF)6H5K10, (AF)6H5K15, (AF)6H5K20 and 
(AF)6H5K25. 
 
Figure 6.6 shows the density profiles of residues and counter ion Cl

 as a 
function of distance from the COM. The micelles examined contain 10, 8 and 6 
peptide chains for (AF)6H5K15, (AF)6H5K20 and (AF)6H5K25, respectively. The 
general trend of the density profile is similar for the three peptides, and a 
core/shell structure is observed. Specifically, hydrophobic Ala and Phe reside in 
the core (0 ~ 1.5 nm), hydrophilic Lys is in the shell (1.5 ~ 4 nm), and 
amphiphilic His is at the interface of core/shell. In addition, Cl
is preferentially 
located in the shell to electrostatically neutralize Lys. From the above simulation 
(a) (AF)6H5K10                                                   (b) (AF)6H5K15 
(c) (AF)6H5K20                                                  (d) (AF)6H5K25 




results, it is revealed that the more hydrophilic content in the peptide reduces the 
self-assembly thus the micelle size. 
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Figure 6.6. Density profiles for (AF)6H5K15, (AF)6H5K20 and (AF)6H5K25. The 
micelles contain 10, 8 and 6 peptides in (a), (b) and (c), respectively. 
 
6.3.2 Replacement of Ala by Phe Residues 
The type of hydrophobic residues effect is examined by considered three peptides 
(AF)6H5K15, (AF3)3H5K15 and F12H5K15. The final snapshots at t = 5000 ns in 
Figure 6.7 indicate that the number of micelles formed is 5, 5, and 4, respectively.  
   
Figure 6.7. Final snapshots for (AF)6H5K15, (AF3)3H5K15 and F12H5K15.  
 
When Ala is replaced by Phe, the size of micelles seems to increase and the 
core is not covered completely by the shell. This is because Phe is more 
hydrophobic and bigger than Ala, which promotes the assembly of larger 
(a) (AF)6H5K15                            (b) (AF)6H5K20                            (c) (AF)6H5K25 
(a) (AF)6H5K15  
(b) (AF3)3H5K15  
(c) F12H5K15  




micelles. No rod-like micelles is observed for (AF)6H5K15, (AF3)3H5K15 and 
F12H5K15. Furthermore, no individual chain exists for these three peptides. This is 
due to the high content of hydrophobic residues, in contrast to (AF)6H5K25 
discussed above. 
Figure 6.8 shows the number of clusters NC versus time for (AF)6H5K15, 
(AF3)3H5K15 and F12H5K15. Similar to Figure 6.3, NC initially decreases rapidly, 
then tends to be slowly, and eventually approaches a constant. While the general 
feature in NC ~ t is close for the three peptides, it is obviously influenced upon 
replacing Ala by Phe. Compared to (AF)6H5K15 and (AF3)3H5K15, F12H5K15 
exhibits faster aggregation (i.e. more rapid reduction at the early stage 0 ~ 500 ns) 
and fewer number of micelles (i.e. larger micelles). This is in accord with the 
observation in Figure 6.7 that the assembly is facilitated by Phe. 
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Figure 6.8. Number of clusters for (AF)6H5K15, (AF3)3H5K15 and F12H5K15. 




































































Figure 6.9. Radii of micelle (Rmicelle), core (Rcore) and shell (Rshell) for (AF)6H5K15, 
(AF3)3H5K15 and F12H5K15. 
The Rmicelle, Rcore and Rshell for (AF)6H5K15, (AF3)3H5K15 and F12H5K15 are 
shown in Figure 6.9. Despite fluctuations, the Rmicelle, Rcore and Rshell are generally 
constant from 4000 to 5000 ns. From Table 6.1, the Rmicelle values for (AF)6H5K15, 
(AF3)3H5K15 and F12H5K15 are about 3.35, 3.42 and 3.71 nm; the Rcore values are 
2.26, 2.36 and 2.43 nm. Thus, the size of micelle increases upon replacing Ala by 
Phe. Nevertheless, the trend of Rshell is slightly different. For (AF)6H5K15 and 
(AF3)3H5K15, the Rshell is nearly the same (1.09 and 1.06 nm); Upon completely 
replacing Ala by Phe, the Rshell for F12H5K15 increases to 1.28 nm. 
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Figure 6.10. Distributions of Rmicelle for (AF)6H5K15, (AF3)3H5K15 and F12H5K15. 
Figure 6.10 shows the distributions of Rmicelle for (AF)6H5K15, (AF3)3H5K15 
and F12H5K15. (AF)6H5K15 and (AF3)3H5K15 exhibit a bimodal distribution ranging 
from 2.5 to 4.6 nm, more preferentially within 3.0 to 3.3 nm. The distribution for 
(a) (AF)6H5K15                            (b) (AF3)3H5K15                           (c) F12H5K15 
(a) (AF)6H5K15                                (b) (AF3)3H5K15                                      (c) F12H5K15 




F12H5K15 is slightly different, ranging from 3.0 to 5.2 nm. This feature is 
consistent with above discussion that the micelles formed by F12H5K15 are larger 
compared to (AF)6H5K15 and (AF3)3H5K15.  
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Figure 6.11. Density profiles for (AF)6H5K15, (AF3)3H5K15 and F12H5K15. The 
micelles contain 5, 6 and 15 peptides in (a), (b) and (c), respectively. 
Figure 6.11 plots the density profiles for (AF)6H5K15, (AF3)3H5K15 and 
F12H5K15. The core/shell structure is clearly seen with Ala and Phe in the core, 
Lys in the shell, and His at the interface of core/shell. In addition, the density 
profile of Phe for F12H5K15 is extended to a longer distance, indicating that 
F12H5K15 assembles into larger micelles than (AF)6H5K15 and (AF3)3H5K15. 
6.3.3 Length of Hydrophobic Residues 
Four peptides F4H5K15, F8H5K15, F12H5K15 and F16H5K15 are examined on how the 
length of hydrophobic residues affects assembly. Figure 6.12 illustrates the 
snapshots at different time intervals. As in Figure 6.2, the assembly process can 
be described in three steps: aggregation of small clusters, then large clusters, 
finally formation of micelles. At a given time, the number of clusters decreases 
with increasing length of Phe residues, but the size of cluster increases.  
 
(a) (AF)6H5K15                           (b) (AF3)3H5K15                           (c) F12H5K15 





       
 
       
 
       
 
       
 
Figure 6.12. Snapshots for F4H5K15, F8H5K15, F12H5K15 and F16H5K15 at different 
time intervals. 
              0 ns                           250 ns                           1000 ns                         5000 ns 
F4H5K15 
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At equilibrium, the number of micelles is 6, 6, 4 and 3 for F4H5K15, F8H5K15, 
F12H5K15 and F16H5K15, respectively. With increasing Phe residues from 4, 8 and 
12 to 16, the micelles tend to shift from spherical to fiber-like. Thus Phe promotes 
aggregation and has a strong effect on the morphology of micelle. For F16H5K15, 
the micelles formed at an early state are spherical; however, Phe residues in the 
core are not completely covered by the shell, and they further assemble into fiber-
like structure. 
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Figure 6.13. Number of clusters versus time for F4H5K15, F8H5K15, F12H5K15 and 
F16H5K15. 
Figure 6.13 shows the number of clusters NC along with simulation time for 
F4H5K15, F8H5K15, F12H5K15 and F16H5K15. The aggregation is slow for F4H5K15, 
with small clusters present till 3500 ns. In contrast, the aggregation is much faster 
for F8H5K15, F12H5K15 and F16H5K15, as evidenced by the rapid reduction of NC 
during the first 300 ns. It is interesting to note for F16H5K15 that NC decreases to 4 
at 400 ns and remains till 4600 ns; thereafter, NC further decreases to 3 
corresponding to the formation of fiber-like structure as illustrated in Figure 6.12.  
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Figure 6.14. Radii of micelle (Rmicelle), core (Rcore) and shell (Rshell) for F4H5K15, 
F8H5K15, F12H5K15 and F16H5K15. 
The Rmicelle, Rcore and Rshell for F4H5K15, F8H5K15, F12H5K15 and F16H5K15 are 
shown in Figure 6.14. As a function of time, the radii for F4H5K15, F8H5K15 and 
F12H5K15 are approximately the same; however, sharp increase is observed at 
4600 ns in Rmicelle and Rcore for F16H5K15. This is due to the formation of fiber-like 
structure as discussed in Figure 6.13. The averaged radii in the last 1000 ns are 
tabulated in Table 6.1. Although the Rmicelle is nearly the same (~ 3.21 nm) for 
F4H5K15 and F8H5K15, the Rmicelle and Rcore generally increase with increasing 
length of Phe residues. This is because the size of micelle increases and more 
peptide chains are present in the micelle for peptide with longer Phe residues. 
(a) F4H5K15                                                      (b) F8H5K15 
(c) F12H5K15                                                    (d) F16H5K15 




Nevertheless, the Rshell decreases from 1.7 to 1.0 nm from F4H5K15 to F16H5K15. 
The reason is that the core becomes larger with increasing length of Phe residues; 
while Lys residues in the shell attempt to cover the core, the shell thus becomes 
thinner with fixed number of Lys residues.  
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Figure 6.15. Distributions of Rmicelle for F4H5K15, F8H5K15, F12H5K15 and 
F16H5K15. 
Figure 6.15 shows the distributions of Rmicelle for F4H5K15, F8H5K15, F12H5K15 
and F16H5K15. F4H5K15 and F8H5K15 exhibit similar distribution ranging from 2.5 
to 4.1 nm, as they have nearly equal number and same size of micelles formed 
(see Table 6.1). With increasing Phe residues to 12 and 16, larger micelles are 
(a) F4H5K15                                                             (b) F8H5K15 
(c) F12H5K15                                                        (d) F16H5K15 




formed. Consequently, the distributions shift toward a larger radius, ranging from 
3.0 to 5.2 nm for F12H5K15, and from 3.0 to 5.5 nm for F16H5K15. 
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Figure 6.16. Density profiles for F4H5K15, F8H5K15 and F16H5K15. The micelles 
contain 9, 11 and 10 peptides in (a), (b) and (c), respectively. 
The density profiles for F4H5K15, F8H5K15 and F16H5K15 are shown in Figure 
6.16. All the three micelles exhibit a clear core/shell structure. Phe is located in 
the core and moves away from the COM with increasing length. For example, Phe 
is located within 0 ~ 1.8 nm for F4H5K15, 0 ~ 2.2 nm for F8H5K15, and 0 ~ 3 nm 
for F16H5K15. This is because the size of micelle increases with increasing length 
of Phe residues. However, the locations of Lys in the shell and of His in the 
core/shell interface remain approximately the same in the three cases, i.e., they are 
not much influenced by the length of Phe residues.  
6.4 Conclusions 
In this Chapter, we have investigated the roles of hydrophilic and hydrophobic 
residues in the self-assembly of (AF)6H5K15 derivatives. The assembly process 
can be represented in three steps: aggregation of small clusters, then large 
clusters, finally formation of micelles. Core/shell structured micelles are observed 
(a) F4H5K15                                 (b) F8H5K15                            (c) F16H5K15 




to form, with hydrophobic Ala and Phe in the core, hydrophilic Lys in the shell, 
and amphiphilic His at the interface.  
Three different cases are examined by varying the length of hydrophilic 
residues, the hydrophobic residue replacement as well as the length of 
hydrophobic residues. (1) With increasing length of Lys from (AF)6H5K10, 
(AF)6H5K15 and (AF)6H5K20 to (AF)6H5K25, assembly capability is reduced, thus 
assembly is slower and micelle size reduces. (2) Upon replacing Ala by more 
hydrophobic Phe in (AF)6H5K15, (AF3)3H5K15 and F12H5K15, micelle size 
increases. (3) With increasing length of Phe in F4H5K15, F8H5K15, F12H5K15 and 
F16H5K15, assembly is faster and micelle size increases. Furthermore, the micelle 
tends to shift from spherical to fiber-like. These simulation findings are 
indispensable to quantitatively understand the roles of hydrophilicity and 
hydrophobicity in the assembly of (AF)6H5K15 derivatives, and would facilitate 
the design of new amphiphilic peptides.  
The current Chapter is focused on the roles of hydrophilic and hydrophobic 
residues. In the next Chapter, the loading and release of a model drug will be 
investigated in FA32. 
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Chapter 7. Ibuprofen Loading and Release in FA32 and its 
Derivatives 
7.1 Introduction 
Chapters 4, 5, and 6 outline the simulation results on the self-assembly of short 
and long peptides. This chapter is focused on the loading and release of a sample 
drug ibuprofen in FA32 peptide and its derivatives. High-efficacy drug delivery is 
crucial to therapeutic treatment.
158
 A handful of amphiphilic materials including 
polymers and liposomes have been used as carriers for drug delivery.
159
 Based on 
their intrinsic self-assembly nature, the carriers form different nano-structures 
such as micelles, vesicles and fibers.
42,173
 These structures can be utilized to 




Recently, amphiphilic peptides have also been explored as drug carriers. They 
are biocompatible, biodegradable, and display a higher level of biological and 
chemical diversity compared with other materials. Their assembled nano-
structures can be readily tuned by tailoring peptide sequence, length and other 
conditions.
145
 A number of experimental studies were reported on amphiphilic 
peptides for drug loading and release. For example, Wiradharma et al. examined a 
peptide (FA32) for simultaneous delivery of drug and gene. FA32 forms micelles 
and exhibits high loading capacity of doxorubicin (DOX) and sustained release.
14
 
They subsequently synthesized oligopeptides with different compositions and 
studied the effects of hydrophobic blocks on self-assembly, drug loading and gene 





 A peptide (RADA16) was observed by Liu et al. to spontaneously 
form a hydrogel under physiological conditions. The hydrogel was effective at 
controlling the release of paclitaxel (PTX) and inhibiting tumor cell growth in 
vitro.
174
 Liang et al. prepared a peptide (VVVVVVKKRGDS) and found the 
formation of spherical micelles, which showed rapid and targeted release of DOX 
upon pH change.
175
 For short lipid-like peptides A6K and A6D, Fatouros et al. 
observed nano-vesicles and necklace-like structures, and further determined the 
release kinetics of pharmaceutically active hydrophilic and hydrophobic model 
drugs (carboxyfluorescein and Nile red).
89
 
Currently, the fundamental understanding of drug loading and release in nano-
structures formed by amphiphilic peptides remains elusive. For such complex 
systems, it is challenging to experimentally measure detailed equilibrium and 
dynamic properties. In this context, molecular simulation is playing increasingly 
more important role in this field. Simulation can provide microscopic insights that 
are inaccessible by experiments and thus unravel the relevant mechanisms from 
bottom-up. For example, simulation studies have been reported on drug loading 
and release in amphiphilic polymers. By dissipative particle dynamics (DPD) 
technique, Guo et al. simulated the diffusion of drug into the core of core/shell 
structured polymeric micelles and examined how loading efficiency was affected 
by various factors including the structure of drug, length of hydrophobic block, 
interaction strength between drug and polymer.
176
 They further simulated the 
micellar structures of a four-arm star triblock copolymer (4AS-PCL-b-PDEAE-
MA-b-PPEGMA), and the loading process and distribution of DOX. When the 
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PDEAEMA blocks were protonated, different morphologies of micelles were 
acquired; in addition, the number and size of surface cracks were found to 
increase.
177
 By integrating DPD and MD simulation, we investigated the loading 
and release of camptothecin (CPT) in a pH-responsive copolymer composed of 
hydrophilic poly(β-amino ester) (PAE) and hydrophobic methyl ether-capped 
poly(ethylene glycol) (PEG). CPT was loaded into the micelles and vesicles 
formed by PAE-PEG, and released by swelling-demicellization-releasing 
mechanism upon protonation.
157
 Jain et al. conducted a fully atomistic MD 
simulation to examine the complexation between PPI dendrimer and two drugs 
(Famotidine and Indomethacin). The dendrimer-drug complexes at low pH were 
found to be less stable compared with those at neutral and high pH, thus drug 
release at low pH was spontaneous.
178
 
Nevertheless, simulation studies for drug in amphiphilic peptides are scarce. 
Herein, we report a MD simulation study for the loading and release of ibuprofen 
(IBU) in peptide FA32 and two derivatives F12H5K15 and F16H5K15. With 
analgesic and antipyretic features, IBU is a widely used non-steroidal anti-
inflammatory drug.
179
 FA32 is an amphiphilic peptide consisting of three blocks 
of amino acids (AF)6H5K15, and was tested for the delivery of drug and gene.
14
 we 
have examined the self-assembly of FA32 and its derivatives by coarse-grained 
MD simulation, and provided microscopic insights into the assembly process and 
morphologies in chapter 5 and 6. In this chapter, we further examine how IBU is 
loaded into and released from their nano-structures. Following this introduction, 
the models and methods used are described in Section 7.2. Particularly, a CG 
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model is developed for IBU. In Section 7.3, IBU loading in FA32 and its 
derivatives is analyzed in detail at different IBU concentrations. The dynamic 
process of loading and equilibrium properties are characterized by the number of 
clusters, morphology sizes and density distributions. Then, the release process is 
examined and compared between FA32 and its derivatives. Finally, the 
concluding remarks are summarized in Section 7.4. 
7.2 Models and Methods 
As in our previous chapters, the CG simulation modelling is used to examine 
IBU loading and release. FA32, F12H5K15 and F16H5K15 are described by the 
MARTINI force field. Figures 7.1a to 7.1f show the atomistic and CG structures 
of FA32, F12H5K15 and F16H5K15. For IBU, a five-bead CG model is developed 
here based on the MARTINI protocol. As illustrated in Figures 7.1g-7.1h, the 
butyl group and phenyl ring in IBU are represented by C1 bead and SC4-SC4-
SC4 (three side chain beads) in the MARTINI model. The propanoic acid is not 
parameterized by the MARTINI model. Nevertheless, the closest bead type is P1 
(C3–OH, 1 or 2-propanol), P2 (C2–OH, ethanol) and P3 (HO–C2=O, acetic 
acid).
136
 The bond lengths between C1–SC4 and SC4–Pn (n = 1, 2 or 3) are not 
known, though the atomistic structure shows a difference of 0.02 nm between 
them. To determine the bead type (P1, P2 or P3) and the bond lengths that can 
best represent the atomistic model of IBU, MD simulations were conducted. 
Specifically, two IBU molecules, using either atomistic or CG model, in water 
were simulated under NPT (isothermal and isobaric) ensemble. The radial 
distribution functions g(r) from both models are shown in Figures 7.2 to 7.4.  










                                   
 
Figure 7.1. Atomistic and coarse-grained structures of (a-b) (AF)6H5K15 (c-d) 
F12H5K15 (e-f) F16H5K15 and (g-h) IBU. In (a), (c), (e) and (g): O, red; N, blue; C, 
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Due to the presence of only two molecules, the g(r) do not approach to one, which 
was also observed in surfactant and glycolipid.
180,181
 Compared with the P1 and 
P2 models, the P3 model exhibits the closest g(r) to the atomistic model despite 
deviation in peak height. Nevertheless, such deviation between the CG and 












Figure 7.3. Radial distribution functions between different groups of IBU in P1, 

















(a) P1                        c             (b) P2                                          (c) P3 
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Furthermore, the P3 model with the bond lengths of 0.34 nm for C1–SC4 and 
0.32 nm for SC4–P3 appear to have the closest g(r) to atomistic model. Therefore, 







Figure 7.4. Radial distribution functions between different groups of IBU at 
different bond lengths. 
P1: (a) C1–SC4:0.30, SC4–P1:0.28 (b) C1–SC4:0.32, SC4–P1:0.30 (c) C1–SC4:0.34, SC4–P1:0.32.  
P2: (d) C1–SC4:0.30, SC4–P2:0.28 (e) C1–SC4:0.32, SC4–P2:0.30 (f) C1–SC4:0.34, SC4–P2:0.32.  
P3: (g) C1–SC4:0.30, SC4–P3:0.28 (h) C1–SC4:0.32, SC4–P3:0.30 (i) C1–SC4:0.34, SC4–P3:0.32. 
 
To examine the loading of IBU, 50 peptide chains and a number of IBU 
molecules were randomly mixed in an 18 nm cubic box. For FA32, various ratios 
of IBU over peptide (D/P = 0.10, 0.15, 0.20, 0.25, 0.30, 0.40, 0.50, 0.60, 0.70 and 
(a) (b) (c) 
(d) (e) (f) 
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0.80) were considered. In order to test the effect of initial configuration, five 
separate simulations with different initial positions of peptide and IBU were 
conducted at D/P = 0.15, 0.20 and 0.25. For F12H5K15 and F16H5K15, the ratio D/P 
was 0.25. In each case, the simulation box was solvated by water molecules and 
neutralization by Cl
 
counter ions. All the other energy minimization methods and 
MD simulations are conducted with the same parameters as mentioned in chapter 
4. At the end of 5 µs simulation for loading, IBU release from FA32 and its 
derivatives was subsequently examined. The pH considered for release was below 
6 and hence His residues were protonated. Moreover, an external force of 0.005 
nm/ps
2
 was applied on solvent to mimic the stirring effect in realistic condition. 
Earlier literature (Journal of Chromatography A, 1216 (2009) 5122–5129; JPCB, 
2009, 113, 15851-15857; Langmuir, 2013, 29, 1650-1656) have used from 0.001 
to 0.05 nm/ps
2
. We conducted different simulations with external force between 
0.001 and 0.0001 nm/ps
2
. The results are qualitatively similar, and the case of 
0.005 is shown. This external force could accelerate simulation and facilitate IBU 
release in a shorter time scale.  
7.3 Results and Discussion 
First, the loading of IBU in FA32 is presented at various ratios, particularly 
focused on D/P = 0.15, 0.20 and 0.25. Then, the loading in F12H5K15 and 
F16H5K15 is examined at D/P = 0.25. The dynamic process and equilibrium 
structures of loading are characterized by the number of clusters, radii and density 
profiles. Finally, the release of IBU from FA32 and F16H5K15 is compared. 
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7.3.1 IBU Loading in FA32 
Figure 7.5 shows the snapshots for IBU loading in FA32 at D/P = 0.15, 0.20 and 
0.25. Water and Cl
 
ions are not shown for clarity. Similar to neat FA32,
182
 the 
assembly process with IBU also follow a three-step process.  
 
    
 
    
 
    
Figure 7.5. Snapshots for IBU loading in FA32 at D/P = 0.15, 0.20 and 0.25. Ala 
and Phe: yellow, His: blue, Lys: red, IBU: green. Water and Cl

 ions are not 
shown for clarity. 
Initially, IBU molecules are attached to Phe and Ala residues in FA32 forming 
small clusters, due to strong hydrophobic interactions between IBU and 
0 ns                         1000 ns                         3000 ns                           5000 ns 
D/P = 0.20 
D/P = 0.25 
0 ns                          1000 ns                         3000 ns                          5000 ns 
0 ns                            1000 ns                        3000 ns                          5000 ns 
D/P = 0.15 
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hydrophobic residues. Then, the small clusters merge with an increase in size. 
Finally, core/shell structured micelles are formed with IBU loaded at the core and 
covered by hydrophilic shell. 
Table 7.1. Number of micelles for IBU loading in FA32 with different initial 
positions. 
 D/P = 0.15 D/P = 0.20 D/P = 0.25 
Run 1 3 3 2 
Run 2 4 2 2 
Run 3 3 2 2 
Run 4 3 2 2 
Run 5 4 2 3 
The final number of micelles at the end of 5 s simulation is listed in Table 
7.1. Run 1-5 represent the simulation with different initial positions. At D/P = 
0.15, the final number is 3 – 4 and reduced to mostly 2 at D/P = 0.20 and 0.25. 
This observation suggests that the final number of micelles is insensitive to the 
initial configuration, thus it is acceptable to conduct a single run. For neat FA32, 
5 micelles were formed for 50 peptide chains in an 18 nm box.
182
 The number of  
t (ns)













Figure 7.6. Number of clusters versus time for IBU loading in FA32 at D/P = 
0.15, 0.20 and 0.25. 
t (ns)
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micelles is thus reduced upon loading IBU due to the enhanced hydrophobic 
interactions; meanwhile, as discussed below, the micelle size becomes larger 
compared with neat FA32. 
To quantify the dynamic process of IBU loading, Figure 7.6 plots the number 
of clusters (NC) versus simulation time. If the distance between any hydrophobic 
beads of two peptide chains is less than a cutoff of 1.5 nm, the two chains are 
considered to be in the same cluster. The cutoff distance here is larger than 0.7 nm 
for FA32 and its derivatives.
182,183
 The reason is that the hydrophobic beads of 
peptide chains move away upon the loading of IBU. At different D/P, the general 
trend of NC ~ t in Figure 7.6 is similar. With increasing time, NC initially 
decreases rapidly, then tends to decrease slowly and eventually approaches a 
constant with fluctuation. This is consistent with the three-step assembly process, 
corresponding to the formation of small clusters, followed by large clusters and 
finally micelles. Near the end of simulation, the fluctuation of NC is small 
indicating the high stability of IBU-loaded micelles. Consequently, the ensemble 
averages were took over the last 1 µs. With increasing D/P, as observed in Table 
7.1, NC is reduced due to the enhanced interactions between drug and peptide. 
The IBU-loaded FA32 micelle consists of hydrophobic core and hydrophilic 
shell. The radii of micelle and core were estimated by equations 4.1 to 4.3 as 
defined in Chapter 4. Figure 7.7 plots the Rmicelle, Rcore and Rshell over the last 1 µs 
for IBU-loaded FA32 micelles at D/P = 0.15, 0.20 and 0.25. Despite fluctuations, 
the radii remain relatively flat implying stable micelles. The time averaged Rmicelle, 
Chapter 7. Ibuprofen Loading and Release in FA32 and its Derivatives 
110 
 
Rcore, and Rshell are listed in Table 7.2. At D/P = 0.15, 0.20, and 0.25, the Rmicelle 
are 4.10, 4.64 and 4.66 nm and the Rcore are 2.81, 3.21 and 3.27 nm, respectively. 
t (ns)























































Figure 7.7. Radii of micelle (Rmicelle), core (Rcore) and shell (Rshell) for IBU-loaded 
FA32 micelles at D/P = 0.15, 0.20 and 0.25. 
For neat FA32, the Rmicelle and Rcore are 3.35 and 2.26 nm. Apparently, the 
radii of micelles increase in the presence of IBU and with increasing D/P. This is 
attributed to the interactions between drug and peptide are enhanced and larger 
micelles are formed. Also observed in Table 7.2 is that the number of peptide 
chains per micelle becomes greater when D/P increases. 
Table 7.2. Number of micelles, peptides per micelle, Rmicelle, Rcore and Rshell for 
IBU loading in FA32. 
a



















 0 5 10 ± 5 3.35 ± 0.05 2.26 ± 0.04 1.09 ± 0.05 
0.10 107 3 17 ± 9 3.95 ± 0.15 2.74 ± 0.11 1.21 ± 0.09 
0.15 166 3 17 ± 3 4.10 ± 0.05 2.81 ± 0.05 1.28 ± 0.05 
0.20 213 2 25 ± 6 4.64 ± 0.08 3.21 ± 0.09 1.43 ± 0.06 
0.25 266 2 25 4.66 ± 0.16 3.27 ± 0.18 1.38 ± 0.06 
0.30 320 2 25 ± 9 4.75 ± 0.18 3.39 ± 0.18 1.35 ± 0.07 
0.50 533 1 50 6.07 ± 0.06 4.73 ± 0.05 1.34 ± 0.06 
0.70 746 1 50 6.30 ± 0.04 4.92 ± 0.06 1.37 ± 0.06 
(a) D/P = 0.15                              (b) D/P = 0.20                              (c) D/P = 0.25 




Figure 7.8 shows the distributions of Rmicelle for IBU-loaded FA32 micelles at 
D/P = 0.15, 0.20 and 0.25. At D/P = 0.15, the distribution lies between 3.8 and 4.6 
nm, implying the existence of micelles with different radii. At D/P = 0.20, there 
are two peaks at approximately 4.3 and 5.0 nm. However, the distribution is 
narrowed within 4.6 ~ 4.8 nm at D/P = 0.25, due to the similar size of micelles. 
These distributions are consistent with the observation in Figure 7.5. 
Radius (nm)


















































Figure 7.8. Distributions of Rmicelle for IBU-loaded FA32 micelles at D/P = 0.15, 
0.20 and 0.25. 
To examine the locations of IBU and different residues in the micelles, Figure 
7.9 shows the density profiles for IBU-loaded FA32 micelles at D/P = 0.15, 0.20 
and 0.25. With increasing D/P, the micelle size becomes larger as observed from 
Figure 7.5. IBU molecules predominantly reside at the core and covered by Phe 
and Ala residues, revealing strong interactions between IBU and hydrophobic 
residues. Lys is primarily located in the shell, while His is at the core/shell 
interface. Because of the electrostatic interaction with positively charged Lys, Cl

 
ion sits preferentially in the shell. The density profiles suggest that the core/shell 
structured micelles are good carrier for hydrophobic IBU, which can be loaded at 
(a) D/P = 0.15   (b) D/P = 0.20   (c) D/P = 0.25  
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Figure 7.9. Density profiles for IBU-loaded FA32 micelles at D/P = 0.15, 0.20 
and 0.25. The micelles contain 16, 31 and 25 peptides in (a), (b) and (c), 
respectively. 
While the discussion above has been focused on D/P = 0.15, 0.20 and 0.25, 
Figure 7.10 further illustrates the final snapshots for IBU loading in FA32 at D/P 
= 0.10 to 0.80. At 5 s, the number of micelles is 3, 2, 2, 1, 1, 1, 1 and 1 
respectively at D/P = 0.10, 0.20, 0.30, 0.40, 0.50, 0.60, 0.70 and 0.80.  
 
    
 
    
Figure 7.10. Final snapshots for IBU loading in FA32 at different D/P. 
(a) D/P = 0.15                                  (b) D/P = 0.20                                (c) D/P = 0.25 
D/P = 0.10                      D/P = 0.20                     D/P = 0.30                    D/P = 0.40 
 D/P = 0.50                    D/P = 0.60                     D/P = 0.70                      D/P = 0.80 
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Apparently, with increasing D/P and more IBU molecules in the system, the 
number of micelles is reduced but the micelle size increases. As seen in Figures 
7.5 and 7.9 at low D/P, IBU molecules are located in the core of micelles, 
whereas they also reside at the shell at high D/P. This indicates that drug 
molecules are not fully covered by peptide chains and directly exposed to water. 
 
t (ns)














































































Figure 7.11. Radii of micelle (Rmicelle), core (Rcore) and shell (Rshell) for IBU-
loaded FA32 micelles at D/P = 0.10, 0.30, 0.50 and 0.70. 
 
Figure 7.11 plots the Rmicelle, Rcore and Rshell at D/P = 0.10, 0.30, 0.50 and 0.70 
during the last 1 µs. The time averaged values are listed in Table 7.2. With 
increasing D/P from 0.10 to 0.70, Rmicelle and Rcore increase from 3.95 and 2.74 to 
(a) D/P = 0.10                                                    (b) D/P = 0.30 
(c) D/P = 0.50                                                    (d) D/P = 0.70 
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6.30 and 4.92 nm, respectively. This is because more drug molecules are loaded 
and the number of peptide chains also increases. However, Rshell first increases 
from 1.21 to 1.43 upon changing D/P = 0.10 to 0.20, but then tends to decrease 
upon further increasing D/P. The decreasing trend at high D/P is because IBU can 
reside at the shell of micelle and not fully covered by peptides. This is indeed 
observed in Figure 7.12 showing density profiles at D/P = 0.70, in which IBU is 
primarily located in the core, but also at the core/shell interface and extended into 
the shell (till 5.0 nm).  
Radius (nm)






























Figure 7.12. Density profile for IBU-loaded FA32 micelle at D/P = 0.70. The 
micelle contains 50 peptides. 
7.3.2 IBU Loading in F12H5K15 and F16H5K15 
Two FA32 derivatives, F12H5K15 and F16H5K15, are further examined for IBU 
loading at D/P = 0.25. Compared with FA32, F12H5K15 and F16H5K15 possess 
higher hydrophobicity. As found in previous chapter 6, F12H5K15 assembles into 
quasi-spherical micelles, whereas F16H5K15 forms elongated fiber-like 
structures.
183
 In the presence of IBU, Figure 7.13 shows the final snapshots (at 5 
s) for IBU loading in FA32, F12H5K15 and F16H5K15. Two spherical micelles 
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with similar shape and size are observed in FA32 (see Figure 7.5). F12H5K15 
forms two quasi-spherical micelles differing in size. In remarkable contrast, 
F16H5K15 form a well-ordered nanofiber. The loading process of IBU in F16H5K15 
revealed that small clusters are initially aggregated into rod-like clusters at less 
than 250 ns, which then merged into a single nanofiber at approximately 1500 ns, 
finally a uniform nanofiber is formed at 2500 ns and remains stable till the end of 
simulation. Among the three peptides, F16H5K15 has the highest hydrophobicity. 
Thus, morphology transition would occur with increasing hydrophobicity. Similar 










Figure 7.13. Final snapshots for IBU loading in FA32, F12H5K15 and F16H5K15 at 
D/P = 0.25.  
 
The nanofiber formed in F16H5K15 has a diameter of around 10 nm. Figure 
7.14 plots the density profiles of IBU and residues in the nanofiber versus the 
distance from the nanofiber center. Due to strong hydrophobic interactions, IBU 
and Phe are mainly located at the core and covered by Lys and His. Lys is 
dominantly at the hydrophilic shell in contact with water, while His is at the 
 (a) (AF)6H5K15                         (b) F12H5K15  
(c) F16H5K15 
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core/shell interface. Although the morphology is different from spherical micelles 
in Figures 7.5 and 7.9, the locations are qualitatively similar.  
 
Figure 7.14. Density profiles for IBU-loaded F16H5K15 nanofiber. The inset 
denotes the cross-section view. 
7.3.3 IBU Release 
After IBU was loaded in FA32 and F16H5K15 at the ratio of D/P = 0.25, IBU 
release was simulated. Histidine has a side chain with a pKa value of 6.04. The 
side chain is protonated for a pH change. However, the number of protonated side 
chains can be estimated by the Henderson-Hasslebalch equation  
pH = pKa + log{[proton acceptor]/[proton donor]} 
For 50 peptide chains of FA32, there are total of 250 side chains. At pH = 7, 6, 
and 5, the number of protonated chains approximately equals to 25, 125, and 225, 
respectively. Chlorine ions are added to neutralize the system. In this way, the 
effect of pH for release is simulated. Figure 7.15 illustrates the release form FA32 
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IBU molecules located near the micelle shell are released and enter into solution. 
With increasing duration, more IBU molecules are released from the core and the 
number of molecules in solution increases. At the end of the simulation (at 5 s), 
the FA32 micelles appear to be slightly looser than their initial structure (at 0 ns). 
Overall, the release of IBU in FA32 micelles exhibits a controlled manner, 





    
    
    
Figure 7.15. IBU release from FA32 micelles. 
 
            0 ns                               50 ns                               100 ns                            250 ns        
       500 ns                              750 ns                            1000 ns                         1500 ns 
      2000 ns                           3000 ns                        4000 ns                          5000 ns       
Chapter 7. Ibuprofen Loading and Release in FA32 and its Derivatives 
118 
 
Figure 7.16 shows the release of IBU from F16H5K15 nanofiber. Similar to 
Figure 7.15, initially only limited IBU molecules are released from the nanofiber 
shell and the number of released IBU molecules increases as simulation 
progresses. At 5 s, however, a greater number of IBU molecules are released 
from F16H5K15 nanofiber compared with FA32 micelles. The reason is that IBU 
molecules in the quasi-spherical FA32 micelles are more closely packed at the 
core and thus more difficult to be released.  
    
    
    
Figure 7.16. IBU release from F16H5K15 nanofiber. 
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Figure 7.17. Cumulative IBU release from FA32 micelles and F16H5K15 
nanofiber. 
Figure 7.17 plots the cumulative IBU release from FA32 micelles and 
F16H5K15 nanofiber. Initially, drug molecules slowly move out form the F16H5K15 
fiber. After a particular time, the molecules on the surface are released and the 
cracks on the surface cause more drug to be released with in short time. The 
sudden increase for F16H5K15 fiber around 1000 ns might be due to this effect. At 
5 s, the total amount of IBU released from FA32 micelles is approximately 15% 
of IBU loaded. From F16H5K15 nanofiber, the total amount released approaches 
15% at 200 ns and around 50% at 5 s. Therefore, the quasi-spherical micelles 
exhibit better controlled release than the nanofiber. 
7.4 Conclusions 
A coarse-grained simulation study has been carried out to investigate IBU loading 
and release in FA32, F12H5K15 and F16H5K15. The MARTINI model is used to 
describe the peptides. For IBU, a model is developed by comparing the radial 
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FA32 leads to the formation of spherical, stable, core/shell structured micelles. 
From density profiles, IBU is predominantly located at the core along with Phe 
and Ala, whereas Lys is in the shell and His is at the core/shell interface. 
Compared with neat FA32, the size of IBU-loaded micelles is larger. The size 
also increases with increasing ratio of drug/peptide, as attributed to enhanced 
hydrophobic interactions. Morphology transition is found to occur with increasing 
hydrophobicity of peptide. Specifically, the loading of IBU in F16H5K15 forms a 
nanofiber with a uniform well-ordered structure. 
For the release of IBU from FA32 micelle and F16H5K15 nanofiber, only a few 
IBU molecules located at the shell are initially released. With increasing time, 
more IBU molecules are released from the core. Comparing with FA32 micelles, 
a larger number of IBU molecules are released from F16H5K15 nanofiber. This is 
because IBU molecules loaded in the core of spherical micelles are more difficult 
to release; therefore, the spherical micelles exhibit better controlled release than 
the nanofiber. This simulation study provides microscopic insights into the 
loading and release of a hydrophobic drug in FA32 and its derivatives, and would 
assist in the development of new amphiphilic peptides for efficient drug delivery. 
The current Chapter examines IBU loading and release in three peptides 
FA32, F12H5K15 and F16H5K15. The next Chapter will be focused on the effect of 
peptide sequence on assembly and IBU loading. 
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Chapter 8. Effects of Peptide Sequence on Self-Assembly 
and Ibuprofen Loading 
8.1 Introduction 
This chapter is focused on the effect of sequences of FA32 peptide on self-
assembly and drug loading. Amphiphilic peptides assemble into a wide variety of 






 which can be used as 
drug delivery carriers.
63,187-189
 The assembly capability depends on many factors 
including concentration, chain length, pH, temperature, ionic strength, etc.
190-193
 
For example, cationic short peptides (A6K, V6K, V6H, KV6, H2V6, V6K2, L6K2) 
formed nanotubes and vesicles at low pH, and membrane-type sheets at high 
pH.
66
 Upon increasing glycine chain length in G4D2, G6D2, G8D2 and G10D2, 
nanovesicles were found to be more preferentially present rather than nanotubes.
23
  
A handful of studies explored the effect of sequence on assembly. Zhao et al. 
observed I4K2 and KI4K were able to form fibrils because of β-sheet capability, 
while I2K2I2 showed no well-defined morphology.
76
 Jun et al. examined ionic 
complementary peptides with same composition and different sequences. 
(AE)4(AK)4 formed globular structures at a neutral pH and fibrils at both acidic 
and basic pH, whereas [(AE)2(AK)2]2 formed fibrils at both pH.
194
 Two peptides 
with 15 residues (K3FLIVIGSI2K3, KhK; KFLK2IVKIGK2SI2, Alt-KhK) with 
same composition were designed and synthesized by Shera and Sun. Fibril 
networks were observed for KhK with β-sheet at all pH; however, different 
Chapter 8. Effects of Sequence on Self-Assembly and Ibuprofen Loading 
122 
 
morphologies (micelles and fibers) were found for Alt-KhK possessing mostly 
random coil at acidic and neutral pH but β-sheet structure at high pH.195  
The above studies demonstrate the importance of sequence on assembly and 
they were primarily focused on short peptides. However, there are rare studies on 
the effect of sequence for long peptides. In Chapters 5 and 6, we have shown the 
assembly of FA32 is affected by concentration. A high concentration led to an 
elongated micelles, in contrast to spherical micelles at a low concentration.
182
 
Moreover, increase in hydrophobic chain length resulted in a fiber-like structure 
and increase in hydrophilic chain length reduced assembly. In this Chapter, we 
further investigate the assembly and ibuprofen loading in FA32 derived peptides, 
which have same composition but different sequences. The methods and models 
are mentioned in Section 8.2. The results are discussed in Section 8.3 including 
the assembly process and properties, as well as the details of ibuprofen loading. 
Finally, the conclusions are summarized in Section 8.4.  
8.2 Models and Methods 
Four different peptides FA32-I, II, III and IV were considered. As examined in 
Chapter 5, FA32-I has a sequence of (AF)6H5K15. In FA32-II [H5(AF)6K15], the 
histidine residues are separated from lysine. In FA32-III [H5K5(AF)6K10], the 
hydrophobic residues are in the middle with hydrophilic residues on either side. 
FA32-IV [(AF)3H5K15(AF)3] is designed with separated hydrophobic residues. All 
the four peptides were described by the MARTINI model, as represented in 
Figure 8.1.  
 









Figure 8.1. Coarse-grained models of FA32-I: (AF)6H5K15, FA32-II: H5(AF)6K15, 
FA32-III: H5K5(AF)6K10 and FA32-IV: (AF)3H5K15(AF)3. Ala and Phe: yellow, 
His: blue, and Lys: red. 
Initially, each peptide was subjected to few 100 ns MD simulation with 
minimized structure formed. The minimized structure was used to build a 
simulation system in an 18 nm box. Each system contained 50 peptide chains 
dissolved in water. For neutralization, sufficient Cl

 ions were added. Both water 
and Cl

 ions were also represented by the MARTINI model. Energy minimization 
and MD simulations were conducted with the same parameters as used in Chapter 
4. A time step of 20 fs was used for integration and trajectory was saved at every 
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averaged. For ibuprofen (IBU) loading, IBU molecules were added keeping a 
drug to peptide (D/P) ratio of 0.25.  
8.3 Results and Discussion 
8.3.1 Effect of Peptide Sequence on Assembly 
Figure 8.2 illustrates the simulation snapshots for FA32-I, II, III and IV at 
different time intervals (0, 250, 1000 and 5000 ns). Water and Cl

 ions are not 
shown for clarity. For the four peptides, small clusters are initially formed and 
merge into big clusters. Nevertheless, the final morphologies are different. Quasi-
spherical micelles of different sizes are observed for FA32-I and FA32-II, 
whereas FA32-III forms two fused micelles along with a spherical micelle and 
FA32-IV forms a sheet-like structure (irregular aggregation) along with the 
presence of small clusters. These clusters are small and not able to form complete 
core/shell structured micelles. The difference in formation of different 
morphologies is exclusively attributed to the effect of peptide sequence. Unlike 
FA32-I and -II, the hydrophilic residues in FA32-III and the hydrophobic residues 
in FA32-IV are separated; therefore, FA32-III and -IV display weaker assembly 
capability. The assembly behavior here is similar to those experimentally reported 
in the literature. For example, S2(FA)2S2C and S4(FA)2C peptides were found to 
form fibrils, while FAS4FAC formed sheet-like structures due to the separation of 
hydrophobic residues.
196
 Similarly, KI4K and I4K2 formed nanofibers, but I2K2I2 
showed no morphology due to the reduction of its β-sheet formation.76  
 




    
 
    
 
    
 
    
 
Figure 8.2. Snapshots for (AF)6H5K15, H5(AF)6K15, H5K5(AF)6K10 and 
(AF)3H5K15(AF)3 at different time intervals. Water and Cl

 ions are not shown. 
  0 ns                          1000 ns                             3000 ns                       5000 ns 
(AF)6H5K15 
    0 ns                           1000 ns                             3000 ns                        5000 ns 
H5(AF)6K15 
   0 ns                          1000 ns                              3000 ns                         5000 ns 
H5K5(AF)6K10 
0 ns                           1000 ns                           3000 ns                         5000 ns 
(AF)3H5K15(AF)3 
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The number of clusters versus time for FA32-I, II, III and IV is shown in 
Figure 8.3. During the first 500 ns, the reduction in NC is almost the same for the 
four peptides. After 1000 ns, subtle difference is observed. Specifically, FA32-IV 
drops slightly faster than the other three. The final number of clusters at 5000 ns 
are 5, 6, 4 and 4 for FA32-I, -II, -III and -IV, respectively. The fluctuations of NC 
during the last 1000 ns are plotted in the inset. Among the four peptides, FA32-I 
exhibits the smallest fluctuation with NC largely remaining a constant (5) and 
FA32-II shows a fluctuation between 6 and 7; however, FA32-III and -IV have a 
larger fluctuation between 3 and 5. These fluctuations are due to the assembly and 
dis-assembly of small clusters with fused micelles or sheet-like structures, 
implying the assembled structures are not completely stable. 
t (ns)














Figure 8.3. Number of clusters versus time for (AF)6H5K15, H5(AF)6K15, 
H5K5(AF)6K10 and (AF)3H5K15(AF)3. 
Figure 8.4 plots the size of the micelles in terms of radii of micelle, core and 
shell during the last 1000 ns. Consistent with Figure 8.3, FA32-I and -II exhibit 
smaller fluctuations compared to FA32-III and -IV. The time averaged of Rmicelle 
are approximately 3.35, 3.21, 3.93 and 3.88 nm for FA32-I, -II, -III and -IV. The 







Chapter 8. Effects of Sequence on Self-Assembly and Ibuprofen Loading 
127 
 
larger values of Rmicelle for FA32-III and -IV are due to the formation of fused 
micelles and sheet-like structures as shown in Figure 8.2. 
t (ns)
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Figure 8.4. Radii of micelle (Rmicelle), core (Rcore) and shell (Rshell) for (AF)6H5K15, 
H5(AF)6K15, H5K5(AF)6K10, and (AF)3H5K15(AF)3. 
The variations of micelle size can be further illustrated by size distributions. 
Figure 8.5 displays the distributions of Rmicelle for FA32-I, -II, -III and -IV. FA32-I 
and -II have similar size distribution between 2.5 to 4.5 nm. Nevertheless, the 
multiple peaks in FA32-I are due to the fluctuations of five micelles formed. 
FA32-III has a distribution between 2.0 to 5.0 nm, and the increase in values 
compared to FA32-I and -II is attributed to the presence of fused micelles. FA32-
(a) (AF)6H5K15                                                     (b) H5(AF)6K15 
(c) H5K5(AF)6K10                                                    (d) (AF)3H5K15(AF)3 
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IV exhibits a wide distribution between 1.5 to 6.7 nm. The peak at 1.5 nm 
represents the smallest cluster in the system and the peak above 6 nm indicates 
sheet-like structure.  
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Figure 8.5. Distributions of Rmicelle for (AF)6H5K15, H5(AF)6K15, H5K5(AF)6K10, 
and (AF)3H5K15(AF)3. 
It is instructive to examine the density profiles of different residues in the 
assembled structures. For three micelles in FA32-I, -II and -III as shown in Figure 
8.6, hydrophobic Phe and Ala residues are dominantly located in the core, while 
hydrophilic Lys residues preferentially reside in the shell.  
 
 (a) (AF)6H5K15                                                       (b) H5(AF)6K15 
(c) H5K5(AF)6K10                                             (d) (AF)3H5K15(AF)3 
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Figure 8.6. Density profiles for (AF)6H5K15, H5(AF)6K15 and H5K5(AF)6K10 
micelles. The micelles contain 5, 10 and 10 peptides in a, b and c, respectively. 
The simulation results reveal that the self-assembly and morphology of 
peptide FA32 are affected by its sequence. The first two peptides FA32-I and -II 
form quasi-spherical micelles, whereas FA32-III and -IV tend to form irregular 
fused micelles and sheet-like structures.  
8.3.2 Effect of Peptide Sequence on IBU Loading 
The four peptides with different sequences are examined for the loading of 
IBU at a ratio D/P = 0.25. Each simulation box (18 nm) contained 50 peptides and 
266 IBU molecules. Figure 8.7 illustrates the snapshots for FA32-I, II, III and IV 
loaded with IBU. Two spherical micelles are formed for FA32-I with IBU, as 
already mentioned in Chapter 7. FA32-II displays two spherical clusters till 3000 
ns, which are fused after 4500 ns. For FA32-III, fused micelles are formed within 
1000 ns and remain for the rest 4000 ns. One fused micelle is observed for FA32-
IV even less than 1000 ns. Nevertheless, at the end of 5000 ns, IBU-loaded FA32-
II, -III and -IV all form a fused micelle. Though the shape of micelle is different, 
the final number appears to be 1. This suggests that when hydrophobic drug is 
loaded, the effect of sequence is less significant on the assembled morphology. 
(a) (AF)6H5K15                            (b) H5(AF)6K15                          (c) H5K5(AF)6K10 




    
 
    
 
    
 
    
 
Figure 8.7. Snapshots for (AF)6H5K15, H5(AF)6K15, H5K5(AF)6K10 and 
(AF)3H5K15(AF)3 loaded with IBU at different time intervals. 
To explore the dynamic assembly process of FA32-I, -II, -III and -IV upon 
IBU loading, Figure 8.8 shows the number of clusters versus time. The assembly 
is more or less similar for the four peptides. During the initial 100 ns, FA32-IV 
        0 ns                            1000 ns                           3000 ns                          5000 ns 
H5(AF)6K15 + IBU  
        0 ns                             1000 ns                          3000 ns                           5000 ns 
H5K5(AF)6K10 + IBU  
        0 ns                              1000 ns                          3000 ns                        5000 ns 
(AF)3H5K5(AF)3 + IBU 
        0 ns                            1000 ns                          3000 ns                           5000 ns 
(AF)6H5K15 + IBU  
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exhibits faster aggregation by forming fewer clusters as shown in the inset. In the 
last 1000 ns, however, all the four peptides display fluctuations in a similar 
manner and no clear distinction is observed among them. 
t (ns)














Figure 8.8. Number of clusters versus time for IBU loading in FA32-I, FA32-II, 
FA32-III and FA32-IV at D/P = 0.25.  
 
8.4 Conclusions 
Four peptides with different sequences are examined for the effects of sequence 
on self-assembly and drug loading. FA32-I [(AF)6H5K15] and FA32-II 
[H5(AF)6K15] are similar in terms of their assembled morphologies, and both form 
quasi-spherical micelles. FA32-III [H5K5(AF)6K15] and FA32-IV 
[(AF)3H5K15(AF)3] form irregular and sheet-like structures along with smaller 
clusters. The difference is attributed to the fact that the hydrophilic residues in 
FA32-III and the hydrophobic residues in FA32-IV are separated. Thus, FA32-III 
and -IV possess weaker assembly capability. Nevertheless, upon loading of IBU, 
the assembly process in the four peptides is similar, despite slight difference 
during initial stage. Except FA32-I, all the other three form a fused micelle.  
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Chapter 9. Conclusions and Recommendations 
9.1 Conclusions 
Through coarse-grained MD simulations, this thesis aims to microscopically 
understand the self-assembly of amphiphilic peptides and their utilization as drug 
delivery carriers. First, the self-assembly of short peptides (Chapter 4) are 
explored and followed by long peptides (Chapters 5 and 6), then the loading and 
release of ibuprofen are examined in Chapter 7, finally the effects of peptide 
sequence on self-assembly and ibuprofen loading are discussed in Chapter 8. The 
main contents of the thesis are outlined below.  
In Chapter 4, a sereis of short peptides FmDn and FmKn are examined. FmKn 
prefer to assemble into quais-spherical micelles, while FmDn tend to form sheet-
like structures. With increasing length of hydrophilic Lys residues in both F3Kn 
and F6Kn, smaller and less stable micelles are formed with larger fluctuations; 
thus the assembly capability decreases. Upon increasing length of hydrophobic 
Phe residues in FmD and FmK, larger and more stable micelles are formed. F3K4 
and F6K8 are found to form quasi-spherical micelles with distinct core/shell 
structure. The optimal ratio of hydrophobic/hydrophilic residues appears to be 
3/4. Upon increasing this ratio, quasi-spherical micelles tend to shift to elliptical 
aggregates; while decreasing this ratio leads to smaller and less stable micelles. 
This ratio found here is signifcant as it can assist in the rational selection of 
appropriate FmKn peptides.  
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In Chapter 5, FA32 [(AF)6H5K15] with 32 residues is simulated. Spherical 
micelles are formed, in which Ala and Phe are located in the core, Lys in the shell 
and His at the interface. Initially, the peptides aggregate into small clusters, then 
merge into large clusters and eventually form micelles. The interactions between 
hydrophobic residues are crucial for the aggregation of small clusters and 
subsequent micellization. In three simulation boxes with size of 11, 15, and 18 
nm, the number of peptides per micelle remains nearly constant. The radii of 
micelle, core and shell are approximately the same. The density profiles of 
residues in the micelles are also similar. These results reveal that the assembled 
structures are largely independent of box size. In nine systems with different 
peptide concentrations, quasi-spherical micelles are observed to change to 
elongated shape at high concentrations. Such molecular level understanding 
provides useful knowledge on the self-assembly of a relatively longer peptide. 
In Chapter 6, the roles of hydrophilic and hydrophobic residues in self-
assembly are examined for FA32 derivatives by varying the length of hydrophilic 
residues, the length of hydrophobic residues, and replacing the hydrophobic 
residues. With increasing length of Lys from (AF)6H5K10, (AF)6H5K15 and 
(AF)6H5K20 to (AF)6H5K25, assembly capability is reduced thus assembly is 
slower and micelle size reduces. With increasing length of Phe in F4H5K15, 
F8H5K15, F12H5K15 and F16H5K15, assembly is faster, micelle size increases, and 
micelle tends to shift from spherical to fiber-like. Upon replacing Ala by more 
hydrophobic Phe in (AF)6H5K15, (AF3)3H5K15 and F12H5K15, micelle size 
increases.  
Chapter 9. Conclusions and Future Recommendations 
134 
 
In Chapter 7, IBU loading and release in FA32, F12H5K15 and F16H5K15 are 
investigated. Through hydrophobic interactions, IBU molecules are loaded into 
the core of micelles. Compared to neat FA32, the size of IBU-loaded micelles is 
larger. The size also increases with increasing ratio of IBU/peptide, as attributed 
to enhanced hydrophobic interactions. Morphology transition is found to occur 
with increasing hydrophobicity of peptide. Specifically, the loading of IBU in 
F16H5K15 forms a nanofiber with a uniform well-ordered structure. Comparing to 
FA32 micelles, a larger number of IBU molecules are released from F16H5K15 
nanofiber. Therefore, the spherical micelles exhibit better controlled release than 
the nanofiber. This simulation study provides microscopic insights into the 
loading and release of a hydrophobic drug in FA32 and its derivatives.  
In Chapter 8, four peptides with different sequence are simulated on the self-
assembly and drug loading. FA32-I [(AF)6H5K15] and FA32-II [H5(AF)6K15] form 
quasi-spherical micelles of different sizes; however, irregular and sheet-like 
structures are formed by FA32-III [H5K5(AF)6K15] and FA32-IV 
[(AF)3H5K15(AF)3]. Therefore, FA32-III and IV exhibit weaker assembly 
capability. This is because the hydrophilic residues in FA32-III and the 
hydrophobic residues in FA32-IV are separated; the interactions for assembly are 
thus reduced. Upon loading of IBU, the assembly process of the four peptides 
does not show much difference, though slight difference during initial stage.  
Overall, this thesis provides microscopic understanding in the self-assembly 
of amphiphilic peptides and the detailed process of drug loading and release. 
Equilibrium and dynamic properties are obtained from a molecular level. Key 
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governing factors such as chain length, hydrophobicity and sequence have been 
identified. The simulation findings would facilitate the design of new amphiphilic 
peptides for tuning morphology and high-efficacy drug delivery.  
9.2 Recommendations for Future Studies  
As an extension of the simulation studies presented in this thesis, the 
recommendations for future studies are suggested below.  
 In Chapter 4, short amphiphilic peptides based on phenylalanine, lysine and 
aspartic acid are examined. Particularly, phenylalanine containing an aromatic 
side chain turns out to be important for assembly. A few other amino acids  
also contain similar aromatic side chain, e.g., tyrosine and tryptophan. They 
can be connected with charged hydrophilic amino acids such as glutamic acid 
and arginine to form various short peptides. It would be interesting to further 
examine these peptides, and tune the ratio of hydrophobic/hydrophilic 
residues towards desired morphologies.  
 In Chapters 7 and 8, spherical micelle and nanofiber are investigated for the 
loading and release of ibuprofen. However, other morphologies (e.g. vesicles) 
can also form by tuning peptide length, cyclic structure, replacement of 
charged residues, etc.
197-200
 Vesicles are capable to deliver both hydrophobic 
and hydrophilic drugs. It should be noted, however, simulation box must be 
sufficiently large to allow vesicles to form.
201
 In addition to ibuprofen, other 
drugs like doxorubicin (DOX) and paclitaxel (PTX), or multi-drug could be 
studied. Nevertheless, appropriate force fields for these drug molecules should 
be developed first as they are not available in the MARTINI model. 
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 The amphiphilic peptides in this thesis contain solely amino acids. As 
introduced earlier, other types of peptides such as lipid-like (carbon chains or 
lipid tails attached to hydrophilic amino acids)
202
 can be simulated. The lipid 
tails have tendency to form β-sheet structures, thus a combination of 
secondary structure (by lipid tails) and random coils (by amino acids) can be 
utilized to design new lipid-like peptides. Furthermore, the length of lipid tails 




 In practical drug delivery, a carrier first encapsulates drug, passes through cell 
membrane, then releases drug. In this thesis, the loading and release of 
ibuprofen in FA32 peptide and its derivatives are simulated in an aqueous 
medium. Possible future studies are to examine the interactions of drug-loaded 
peptides with bilayers or vesicles (as models for cell membranes).
204
 
However, such simulation studies require extra-large computational resources.   
 The MARTINI model has a limitation to mimic secondary structure transition 
during simulation.
205
 In this thesis, all the peptides are assumed to be random 
coiled. However, it is intriguing to explore the effect of secondary structure on 
self-assembly and assembled structures. The proper length and variation of 
secondary structures from experimental studies
206
 on other systems can be 
utilized as a guidance to kick off such further studies. 
 Though simulations are accelerated by coarse-grained models, atomistic 
details such as hydrogen bonding cannot be easily quantified. To overcome 
this, coarse-grained models can be reversed back to atomistic structures and 
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thus provide more microscopic information.
207
 Alternatively, multiscale 
descriptions can be adopted for peptide and water molecules. For example, 
peptide is represented by atomistic model whereas water is mimicked by 
coarse-grained model. By doing this, simulation is accelerated and atomistic 
details of peptide are preserved. The MARTINI model allows such hybrid 
simulation
208
 and can be applied in future studies.  
 The dynamic properties including cluster size and morphology transition as a 
function of time, drug loading and release processes are studied using MD 
simulations in this thesis. The kinetic data such as diffusivity of IBU in the 
micelles cannot be calculated by the common MD method used here, which 
can be determined by applying transition-state theory. 
 Our simulation reveals that a ratio of ¾ phenylalanine to lysine residues 
favors the formation of spherical micelles. The same ratio may be utilized to 
design other amphiphilic peptides (e.g. F3K4, F6K8, F9K12). These peptides 
could be studied experimentally to examine their morphologies. 
 Peptide F16H5K15 forms elongated micelles but uniform fibers upon the 
loading of drug molecules. Similar peptides with different hydrophobic 
residues (e.g. F16H5K15,
 
W16H5K15, Y16H5K15) could be synthesized 
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